{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:24:03Z","timestamp":1788967443993,"version":"build-2803163510"},"reference-count":257,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"DOI":"10.1007\/s43440-026-00897-9","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T13:17:04Z","timestamp":1788959824000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Gut microbiota as a modulator of HDAC: insights into Alzheimer\u2019s disease treatment"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5684-1269","authenticated-orcid":false,"given":"Ekta","family":"Verma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6140-5218","authenticated-orcid":false,"given":"Shweta","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9110-606X","authenticated-orcid":false,"given":"Hanish Singh Jayasingh","family":"Chellammal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4698-9761","authenticated-orcid":false,"given":"Prasanna Shama","family":"Khandige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2165-8373","authenticated-orcid":false,"given":"Amin","family":"Gasmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"issue":"2","key":"897_CR1","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3390\/antiox12020517","volume":"12","author":"EO Olufunmilayo","year":"2023","unstructured":"Olufunmilayo EO, Gerke-Duncan MB, Holsinger RD. Oxidative stress and antioxidants in neurodegenerative disorders. Antioxidants. 2023;12(2):517.","journal-title":"Antioxidants"},{"issue":"1","key":"897_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.apsb.2024.10.004","volume":"15","author":"UC Dash","year":"2025","unstructured":"Dash UC, Bhol NK, Swain SK, Samal RR, Nayak PK, Raina V, Panda SK, et al. Oxidative stress and inflammation in the pathogenesis of neurological disorders: mechanisms and implications. Acta Pharm Sin B. 2025;15(1):15\u201334.","journal-title":"Acta Pharm Sin B"},{"key":"897_CR3","doi-asserted-by":"publisher","first-page":"1616232","DOI":"10.3389\/fpubh.2025.1616232","volume":"13","author":"M Hou","year":"2025","unstructured":"Hou M, Yang L. Trends and forecasts of the prevalence and mortality of Alzheimer\u2019s disease and other dementias in china. Front Public Health. 2025;13:1616232.","journal-title":"Front Public Health"},{"issue":"1","key":"897_CR4","first-page":"43","volume":"15","author":"M Nasb","year":"2023","unstructured":"Nasb M, Tao W, Chen N. Alzheimer\u2019s disease puzzle: delving into pathogenesis hypotheses. Aging Dis. 2023;15(1):43\u201373.","journal-title":"Aging Dis"},{"issue":"7","key":"897_CR5","doi-asserted-by":"publisher","first-page":"104052","DOI":"10.1016\/j.drudis.2024.104052","volume":"29","author":"M Pereira","year":"2024","unstructured":"Pereira M, Cruz MT, Fortuna A, Bicker J. Restoring the epigenome in alzheimer\u2019s disease: advancing HDAC inhibitors as therapeutic agents. Drug discov today. 2024;29(7):104052.","journal-title":"Drug discov today"},{"issue":"1","key":"897_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40035-017-0089-1","volume":"6","author":"SS Yang","year":"2017","unstructured":"Yang SS, Zhang R, Wang G, Zhang YF. The development prospection of HDAC inhibitors as a potential therapeutic direction in Alzheimer\u2019s disease. Transl Neurodegener. 2017;6(1):19.","journal-title":"Transl Neurodegener"},{"issue":"4","key":"897_CR7","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1093\/advances\/nmaa181","volume":"12","author":"K Berding","year":"2021","unstructured":"Berding K, Vlckova K, Marx W, Schellekens H, Stanton C, Clarke G, Jacka F, et al. Diet and the microbiota\u2013gut\u2013brain axis: sowing the seeds of good mental health. Adv Nutr. 2021;12(4):1239\u201385.","journal-title":"Adv Nutr"},{"issue":"1","key":"897_CR8","doi-asserted-by":"publisher","first-page":"2387800","DOI":"10.1080\/19490976.2024.2387800","volume":"16","author":"M Zhuang","year":"2024","unstructured":"Zhuang M, Zhang X, Cai J. Microbiota\u2013gut\u2013brain axis: interplay between microbiota, barrier function and lymphatic system. Gut Microbes. 2024;16(1):2387800.","journal-title":"Gut Microbes"},{"issue":"1","key":"897_CR9","doi-asserted-by":"publisher","first-page":"2483780","DOI":"10.1080\/19490976.2025.2483780","volume":"17","author":"B Thulasinathan","year":"2025","unstructured":"Thulasinathan B, Suvilesh KN, Maram S, Grossmann E, Ghouri Y, Teixeiro EP, et al. The impact of gut microbial short-chain fatty acids on colorectal cancer development and prevention. Gut Microbes. 2025;17(1):2483780.","journal-title":"Gut Microbes"},{"issue":"10","key":"897_CR10","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/j.jalz.2019.07.002","volume":"15","author":"B Li","year":"2019","unstructured":"Li B, He Y, Ma J, Huang P, Du J, Cao L, et al. Mild cognitive impairment has similar alterations as alzheimer\u2019s disease in gut microbiota. Alzheimer\u2019s Dement. 2019;15(10):1357\u201366.","journal-title":"Alzheimer\u2019s Dement"},{"key":"897_CR11","unstructured":"Harach T, Marungruang N, Dutilleul N, Cheatham V, Mc Coy KD, Neher JJ, et al. Reduction of alzheimer\u2019s disease beta-amyloid pathology in the absence of gut microbiota. arXiv. 2015;1509.02273."},{"issue":"1","key":"897_CR12","doi-asserted-by":"publisher","first-page":"30028","DOI":"10.1038\/srep30028","volume":"6","author":"MR Minter","year":"2016","unstructured":"Minter MR, Zhang C, Leone V, Ringus DL, Zhang X, Oyler-Castrillo P, et al. Antibiotic-induced perturbations in gut microbial diversity influence neuro-inflammation and amyloidosis in a murine model of alzheimer\u2019s disease. Sci Rep. 2016;6(1):30028.","journal-title":"Sci Rep"},{"issue":"2","key":"897_CR13","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3233\/JAD-160926","volume":"56","author":"C Brandscheid","year":"2017","unstructured":"Brandscheid C, Schuck F, Reinhardt S, Sch\u00e4fer KH, Pietrzik CU, Grimm M, et al. Altered gut microbiome composition and tryptic activity of the 5xfad alzheimer\u2019s mouse model. J Alzheimers Dis. 2017;56(2):775\u201388.","journal-title":"J Alzheimers Dis"},{"issue":"11","key":"897_CR14","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1136\/gutjnl-2021-326269","volume":"71","author":"C Chen","year":"2022","unstructured":"Chen C, Liao J, Xia Y, Liu X, Jones R, Haran J, et al. Gut microbiota regulate alzheimer\u2019s disease pathologies and cognitive disorders via pufa-associated neuroinflammation. Gut. 2022;71(11):2233\u201352.","journal-title":"Gut"},{"key":"897_CR15","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.bbi.2021.09.002","volume":"98","author":"N Kim","year":"2021","unstructured":"Kim N, Jeon SH, Ju IG, Gee MS, Do J, Oh MS, et al. Transplantation of gut microbiota derived from alzheimer\u2019s disease mouse model impairs memory function and neurogenesis in C57BL\/6 mice. Brain Behav Immun. 2021;98:357\u201365.","journal-title":"Brain Behav Immun"},{"issue":"31","key":"897_CR16","doi-asserted-by":"publisher","first-page":"0466","DOI":"10.1126\/sciadv.aba0466","volume":"6","author":"C Chen","year":"2020","unstructured":"Chen C, Ahn EH, Kang SS, Liu X, Alam A, Ye K. Gut dysbiosis contributes to amyloid pathology, associated with C\/Ebp\u03b2\/AEP signalling activation in Alzheimer\u2019s disease Mouse Model. Sci Adv. 2020;6(31):0466.","journal-title":"Sci Adv"},{"issue":"12","key":"897_CR17","doi-asserted-by":"publisher","first-page":"4916","DOI":"10.1093\/brain\/awad303","volume":"146","author":"S Grabrucker","year":"2023","unstructured":"Grabrucker S, Marizzoni M, Silajd\u017ei\u0107 E, Lopizzo N, Mombelli E, Nicolas S, et al. Microbiota from Alzheimer\u2019s patients induce deficits in cognition and hippocampal neurogenesis. Brain. 2023;146(12):4916\u201334.","journal-title":"Brain"},{"issue":"1","key":"897_CR18","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s40168-022-01243-w","volume":"29","author":"A Parker","year":"2022","unstructured":"Parker A, Romano S, Ansorge R, Aboelnour A, Le Gall G, Savva GM, et al. Faecal microbiota transfer between young and aged mice reverses hallmarks of the ageing gut, eye, and brain. Microbiome. 2022;29(1):68.","journal-title":"Microbiome"},{"issue":"1","key":"897_CR19","doi-asserted-by":"publisher","first-page":"477","DOI":"10.18632\/aging.203826","volume":"14","author":"CC Hung","year":"2022","unstructured":"Hung CC, Chang CC, Huang CW, Nouchi R, Cheng CH. Gut microbiota in patients with alzheimer\u2019s disease spectrum: a systematic review and meta-analysis. Aging. 2022;14(1):477.","journal-title":"Aging"},{"issue":"1","key":"897_CR20","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13195-025-01683-0","volume":"17","author":"H Zhao","year":"2025","unstructured":"Zhao H, Zhou X, Song Y, Zhao W, Sun Z, Zhu J, et al. Multi-omics analyses identify gut microbiota-faecal metabolites-brain-cognition pathways in the alzheimer\u2019s disease continuum. Alzheimer\u2019s Res Ther. 2025;17(1):36.","journal-title":"Alzheimer\u2019s Res Ther"},{"issue":"1","key":"897_CR21","doi-asserted-by":"publisher","first-page":"13537","DOI":"10.1038\/s41598-017-13601-y","volume":"7","author":"NM Vogt","year":"2017","unstructured":"Vogt NM, Kerby RL, Dill-McFarland KA, Harding SJ, Merluzzi AP, Johnson SC, et al. Gut microbiome alterations in Alzheimer\u2019s disease. Sci Rep. 2017;7(1):13537.","journal-title":"Sci Rep"},{"issue":"1","key":"897_CR22","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13195-025-01769-9","volume":"17","author":"KC Fan","year":"2025","unstructured":"Fan KC, Lin CC, Chiu YL, Koh SH, Liu YC, Chuang YF. Compositional and functional gut microbiota alterations in mild cognitive impairment: links to Alzheimer\u2019s disease pathology. Alzheimer\u2019s Res Ther. 2025;17(1):122.","journal-title":"Alzheimer\u2019s Res Ther"},{"issue":"700","key":"897_CR23","doi-asserted-by":"publisher","first-page":"2984","DOI":"10.1126\/scitranslmed.abo2984","volume":"15","author":"AL Ferreiro","year":"2023","unstructured":"Ferreiro AL, Choi J, Ryou J, Newcomer EP, Thompson R, Bollinger RM, et al. Gut microbiome composition may be an indicator of preclinical Alzheimer\u2019s Disease. Sci Transl Med. 2023;15(700):2984.","journal-title":"Sci Transl Med"},{"issue":"1","key":"897_CR24","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/s12877-020-01644-2","volume":"20","author":"V Stadlbauer","year":"2020","unstructured":"Stadlbauer V, Engertsberger L, Komarova I, Feldbacher N, Leber B, Pichler G, et al. Dysbiosis, gut barrier dysfunction and inflammation in dementia: a pilot study. BMC Geriatr. 2020;20(1):248.","journal-title":"BMC Geriatr"},{"issue":"4","key":"897_CR25","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.3233\/JAD-180176","volume":"63","author":"ZQ Zhuang","year":"2018","unstructured":"Zhuang ZQ, Shen LL, Li WW, Fu X, Zeng F, Gui L, L\u00fc Y, et al. Gut microbiota is altered in patients with Alzheimer\u2019s disease. J Alzheimers Dis. 2018;63(4):1337\u201346.","journal-title":"J Alzheimers Dis"},{"key":"897_CR26","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.neurobiolaging.2016.08.019","volume":"49","author":"A Cattaneo","year":"2017","unstructured":"Cattaneo A, Cattane N, Galluzzi S, Provasi S, Lopizzo N, Festari C, et al. Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiol Ageing. 2017;49:60\u20138.","journal-title":"Neurobiol Ageing"},{"issue":"14","key":"897_CR27","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.2174\/1570159X22666240308090741","volume":"22","author":"C Liang","year":"2024","unstructured":"Liang C, Pereira R, Zhang Y, Rojas OL. Gut microbiome in alzheimer\u2019s disease: from mice to humans. Curr Neuropharmacol. 2024;22(14):2314\u201329.","journal-title":"Curr Neuropharmacol"},{"key":"897_CR28","doi-asserted-by":"publisher","first-page":"634069","DOI":"10.3389\/fcell.2020.634069","volume":"8","author":"Z Ling","year":"2021","unstructured":"Ling Z, Zhu M, Yan X, Cheng Y, Shao L, Liu X, et al. Structural and functional dysbiosis of fecal microbiota in chinese patients with Alzheimer\u2019s disease. Front Cell Dev Biol. 2021;8:634069.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"897_CR29","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3233\/JAD-201040","volume":"80","author":"M Guo","year":"2021","unstructured":"Guo M, Peng J, Huang X, Xiao L, Huang F, Zuo Z. Gut microbiome features of Chinese patients newly diagnosed with Alzheimer\u2019s disease or mild cognitive impairment. J Alzheimers Dis. 2021;80(1):299\u2013310.","journal-title":"J Alzheimers Dis"},{"key":"897_CR30","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.bbi.2019.05.008","volume":"80","author":"P Liu","year":"2019","unstructured":"Liu P, Wu L, Peng G, Han Y, Tang R, Ge J, et al. Altered microbiomes distinguish Alzheimer\u2019s disease from amnestic mild cognitive impairment and health in a Chinese cohort. Brain Behav Immun. 2019;80:633\u201343.","journal-title":"Brain Behav Immun"},{"key":"897_CR31","doi-asserted-by":"publisher","first-page":"1243390","DOI":"10.3389\/fnut.2023.1243390","volume":"10","author":"Y Li","year":"2023","unstructured":"Li Y, Huang Y, Liang H, Wang W, Li B, Liu T, et al. The roles and applications of short-chain fatty acids derived from microbial fermentation of dietary fibres in human cancer. Front Nutr. 2023;10:1243390.","journal-title":"Front Nutr"},{"key":"897_CR32","doi-asserted-by":"publisher","first-page":"113290","DOI":"10.1016\/j.biopha.2022.113290","volume":"153","author":"D Li","year":"2022","unstructured":"Li D, Li Y, Yang S, Lu J, Jin X, Wu M. Diet-gut microbiota-epigenetics in metabolic diseases: from mechanisms to therapeutics. Biomed Pharmacother. 2022;153:113290.","journal-title":"Biomed Pharmacother"},{"key":"897_CR33","volume-title":"Genetics, epigenetic mechanisms","author":"NM Aboud","year":"2025","unstructured":"Aboud NM, Tupper C, Jialal I. Genetics, epigenetic mechanisms. Treasure island (FL): StatPearls Publishing; 2025."},{"key":"897_CR34","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.bonr.2017.08.001","volume":"7","author":"NC Huynh","year":"2017","unstructured":"Huynh NC, Everts V, Ampornaramveth RS. Histone deacetylases and their roles in mineralized tissue regeneration. Bone Rep. 2017;7:33\u201340.","journal-title":"Bone Rep"},{"key":"897_CR35","doi-asserted-by":"publisher","first-page":"899013","DOI":"10.3389\/fmolb.2022.899013","volume":"9","author":"Y Jing","year":"2022","unstructured":"Jing Y, Li X, Liu Z, Li XD. Roles of negatively charged histone lysine acylations in regulating nucleosome structure and dynamics. Front Mol Biosci. 2022;9:899013.","journal-title":"Front Mol Biosci"},{"key":"897_CR36","doi-asserted-by":"crossref","unstructured":"Chen HP, Zhao YT, Zhao TC. Histone deacetylases and mechanisms of regulation of gene expression. Crit Rev Oncog. 2015;20(1\u20132):35\u201347.","DOI":"10.1615\/CritRevOncog.2015012997"},{"issue":"5","key":"897_CR37","doi-asserted-by":"publisher","first-page":"556","DOI":"10.3390\/genes11050556","volume":"11","author":"G Milazzo","year":"2020","unstructured":"Milazzo G, Mercatelli D, Di Muzio G, Triboli L, De Rosa P, Perini G, Giorgi FM. Histone deacetylases (HDAC): evolution, specificity, role in transcriptional complexes, and pharmacological actionability. Genes. 2020;11(5):556.","journal-title":"Genes"},{"key":"897_CR38","doi-asserted-by":"publisher","first-page":"143269","DOI":"10.1155\/2011\/143269","volume":"2011","author":"K Xu","year":"2011","unstructured":"Xu K, Dai XL, Huang HC, Jiang ZF, Targeting HDAC. A promising therapy for Alzheimer\u2019s disease. Oxid Med Cell Longev. 2011;2011:143269.","journal-title":"Oxid Med Cell Longev"},{"key":"897_CR39","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3389\/fnmol.2016.00114","volume":"9","author":"Y Wu","year":"2016","unstructured":"Wu Y, Hou F, Wang X, Kong Q, Han X, Bai B. Aberrant expression of histone deacetylases 4 in cognitive disorders: molecular mechanisms and a potential target. Front Mol Neurosci. 2016;9:114.","journal-title":"Front Mol Neurosci"},{"key":"897_CR40","doi-asserted-by":"publisher","first-page":"107410","DOI":"10.1016\/j.phrs.2024.107410","volume":"208","author":"LY Zhang","year":"2024","unstructured":"Zhang LY, Zhang SY, Wen R, Zhang TN, Yang N. Role of histone deacetylases and their inhibitors in neurological diseases. Pharmacol Res. 2024;208:107410.","journal-title":"Pharmacol Res"},{"issue":"2","key":"897_CR41","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s12276-020-0382-4","volume":"52","author":"SY Park","year":"2020","unstructured":"Park SY, Kim JS. A short guide to histone deacetylases including recent progress on class II enzymes. Exp Mol Med. 2020;52(2):204\u201312.","journal-title":"Exp Mol Med"},{"issue":"2","key":"897_CR42","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/bpa.12647","volume":"29","author":"DB Wang","year":"2019","unstructured":"Wang DB, Kinoshita C, Kinoshita Y, Sopher BL, Uo T, Lee RJ, Kim JK, et al. Neuronal susceptibility to beta-amyloid toxicity and ischemic injury involves histone deacetylase\u20102 regulation of Endophilin\u2010B1. Brain Pathol. 2019;29(2):164\u201375.","journal-title":"Brain Pathol"},{"issue":"5","key":"897_CR43","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1111\/acel.12642","volume":"16","author":"X Zhu","year":"2017","unstructured":"Zhu X, Wang S, Yu L, Jin J, Ye X, Liu Y, et al. HDAC 3 negatively regulates spatial memory in a mouse model of Alzheimer\u2019s disease. Aging Cell. 2017;16(5):1073\u201382.","journal-title":"Aging Cell"},{"key":"897_CR44","first-page":"1","volume":"8","author":"K Asadi","year":"2025","unstructured":"Asadi K, K R, Satarker S, Gurram PC. Histone deacetylase 2 in Alzheimer\u2019s disease: a comprehensive molecular blueprint for therapeutic targeting. Mol Neurobiol. 2025;8:1\u201323.","journal-title":"Mol Neurobiol"},{"issue":"16","key":"897_CR45","doi-asserted-by":"publisher","first-page":"8633","DOI":"10.3390\/ijms22168633","volume":"22","author":"YA Chen","year":"2021","unstructured":"Chen YA, Lu CH, Ke CC, Chiu SJ, Chang CW, Yang BH, Gelovani JG, Liu RS. Evaluation of class IIa histone deacetylases expression and in vivo epigenetic imaging in a transgenic mouse model of Alzheimer\u2019s disease. Int J Mol Sci. 2021;22(16):8633.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"897_CR46","doi-asserted-by":"publisher","first-page":"119275","DOI":"10.1016\/j.bbamcr.2022.119275","volume":"1869","author":"T Qureshi","year":"2022","unstructured":"Qureshi T, Chinnathambi S. Histone deacetylase-6 modulates tau function in Alzheimer\u2019s disease. Biochim Biophys Acta Mol Cell Res. 2022;1869(8):119275.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"897_CR47","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/bs.apcsb.2024.09.008","volume":"143","author":"S Chinnathambi","year":"2025","unstructured":"Chinnathambi S. Histone deacetylase regulates tau function in Alzheimer\u2019s disease. Adv Protein Chem Struct Biol. 2025;143:339\u201361.","journal-title":"Adv Protein Chem Struct Biol"},{"issue":"1","key":"897_CR48","doi-asserted-by":"publisher","first-page":"4171","DOI":"10.1038\/s41467-022-30653-5","volume":"13","author":"TA Pascoal","year":"2022","unstructured":"Pascoal TA, Chamoun M, Lax E, Wey HY, Shin M, Ng KP, Kang MS, Mathotaarachchi S, Benedet AL, Therriault J, Lussier FZ. [11\u00a0C] Martinostat PET analysis reveals reduced HDAC I availability in Alzheimer\u2019s disease. Nat Commun. 2022;13(1):4171.","journal-title":"Nat Commun"},{"issue":"1","key":"897_CR49","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1038\/s41467-020-16361-y","volume":"11","author":"PC Pao","year":"2020","unstructured":"Pao PC, Patnaik D, Watson LA, Gao F, Pan L, Wang J, Adaikkan C, Penney J, et al. HDAC1 modulates OGG1-initiated oxidative DNA damage repair in the aging brain and Alzheimer\u2019s disease. Nat Commun. 2020;11(1):2484.","journal-title":"Nat Commun"},{"key":"897_CR50","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1021\/acschemneuro.0c00308","volume":"12","author":"D Patnaik","year":"2021","unstructured":"Patnaik D, Pao PC, Zhao WN, Silva MC, Hylton NK, Chindavong PS, et al. Exifone is a potent HDAC1 activator with neuroprotective activity in human neuronal models of neurodegeneration. ACS Chem Neurosci. 2021;12:271\u201384.","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"897_CR51","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s12640-024-00693-4","volume":"42","author":"L Zhang","year":"2024","unstructured":"Zhang L, Zhu B, Zhou X, Ning H, Zhang F, Yan B, et al. ZNF787 and HDAC1 mediate blood\u2013brain barrier permeability in an in-vitro model of Alzheimer\u2019s disease microenvironment. Neurotox Res. 2024;42(1):12.","journal-title":"Neurotox Res"},{"issue":"4","key":"897_CR52","doi-asserted-by":"publisher","first-page":"382","DOI":"10.2174\/1567205017666200422155323","volume":"17","author":"C Hu","year":"2020","unstructured":"Hu C, Hu J, Meng X, Zhang H, Shen H, Huang P, et al. L1CAM beneficially inhibits histone deacetylase 2 expression under conditions of Alzheimer\u2019s disease. Curr Alzheimer Res. 2020;17(4):382\u201392.","journal-title":"Curr Alzheimer Res"},{"issue":"7","key":"897_CR53","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1080\/00207454.2022.2150190","volume":"2","author":"H Dubey","year":"2024","unstructured":"Dubey H, Dubey A, Gulati K, Ray A. S. Nitrosoglutathione modulates HDAC2 and bdnf levels in the brain and improves cognitive deficits in an experimental model of Alzheimer\u2019s disease in rats. Int J Neurosci. 2024;2(7):777\u201385.","journal-title":"Int J Neurosci"},{"issue":"3","key":"897_CR54","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.ymthe.2017.01.018","volume":"25","author":"D Liu","year":"2017","unstructured":"Liu D, Tang H, Li XY, Deng MF, Wei N, Wang X, et al. Targeting the HDAC2\/HNF-4A\/Mir-101b\/AMPK pathway rescues tauopathy and dendritic abnormalities in Alzheimer\u2019s disease. Mol Ther. 2017;25(3):752\u201364.","journal-title":"Mol Ther"},{"key":"897_CR55","first-page":"1","volume":"24","author":"Y Li","year":"2025","unstructured":"Li Y, Izhar T, Kanekiyo T. HDAC3 as an emerging therapeutic target for Alzheimer\u2019s disease and other neurological disorders. Mol Neurobiol. 2025;24:1\u20133.","journal-title":"Mol Neurobiol"},{"key":"897_CR56","doi-asserted-by":"publisher","first-page":"1419685","DOI":"10.3389\/fimmu.2024.1419685","volume":"15","author":"N Watson","year":"2024","unstructured":"Watson N, Kuppuswamy S, Ledford WL, Sukumari-Ramesh S. The role of HDAC3 in inflammation: mechanisms and therapeutic implications. Front Immunol. 2024;15:1419685.","journal-title":"Front Immunol"},{"issue":"8","key":"897_CR57","doi-asserted-by":"publisher","first-page":"E13895","DOI":"10.1111\/acel.13895","volume":"22","author":"D Marinho","year":"2023","unstructured":"Marinho D, Ferreira IL, Lorenzoni R, Cardoso SM, Santana I, Rego AC. Reduction of class I histone deacetylases ameliorates ER- mitochondria cross-talk in Alzheimer\u2019s disease. Aging Cell. 2023;22(8):E13895.","journal-title":"Aging Cell"},{"issue":"1","key":"897_CR58","doi-asserted-by":"publisher","first-page":"E12861","DOI":"10.1111\/nan.12861","volume":"49","author":"C Colussi","year":"2023","unstructured":"Colussi C, Aceto G, Ripoli C, Bertozzi A, Li Puma DD, Paccosi E, et al. Cytoplasmic HDAC4 recovers synaptic function in the 3\u00d7 Tg mouse model of Alzheimer\u2019s disease. Neuropathol Appl Neurobiol. 2023;49(1):E12861.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"6","key":"897_CR59","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/s41386-023-01775-1","volume":"49","author":"X Dai","year":"2024","unstructured":"Dai X, Lin A, Zhuang L, Zeng Q, Cai L, Wei Y, et al. Targeting SIK3 to modulate hippocampal synaptic plasticity and cognitive function by regulating the transcription of hdac4 in a mouse model of Alzheimer\u2019s disease. Neuropsychopharmacology. 2024;49(6):942\u201352.","journal-title":"Neuropsychopharmacology"},{"key":"897_CR60","doi-asserted-by":"crossref","unstructured":"Huang N, Hong R, Cui X, Cao L, Shi L, Chen B et al. Targeting the HDAC4-NHE6-endosomal pH axis restores amyloid-\u03b2 clearance and cognitive function in Alzheimer\u2019s disease mice. J Nanobiotechnol. 2026 Apr 3 (In press).","DOI":"10.1186\/s12951-026-04297-2"},{"key":"897_CR61","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3389\/fncel.2015.00042","volume":"9","author":"M Mielcarek","year":"2015","unstructured":"Mielcarek M, Zielonka D, Carnemolla A, Marcinkowski JT, Guidez F. HDAC4 as a potential therapeutic target in neurodegenerative diseases: a summary of recent achievements. Front Cell Neurosci. 2015;9:42.","journal-title":"Front Cell Neurosci"},{"issue":"17","key":"897_CR62","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.3390\/cells14171338","volume":"14","author":"LP Diniz","year":"2025","unstructured":"Diniz LP, Pinheiro PD, Franco LS, Gomes FC. HDAC in the brain: From chromatin remodelling to neurodegenerative disease. Cells. 2025;14(17):1338.","journal-title":"Cells"},{"key":"897_CR63","doi-asserted-by":"publisher","first-page":"E076368","DOI":"10.1002\/alz.076368","volume":"19","author":"Y Lee","year":"2023","unstructured":"Lee Y, Lee J, Jo DG. Roles of HDAC6 in the pathogenesis of Alzheimer\u2019s disease. Alzheimers Dement. 2023;19:E076368.","journal-title":"Alzheimers Dement"},{"key":"897_CR64","doi-asserted-by":"crossref","unstructured":"Wang X, Li C, Chen L, He B, Li Y. Therapeutic potential of dual HDAC6\/SIRT2 inhibition in Alzheimer\u2019s disease. Eur J Med Chem. 2025 May;9:117733.","DOI":"10.1016\/j.ejmech.2025.117733"},{"issue":"1","key":"897_CR65","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13024-025-00796-2","volume":"20","author":"J Ye","year":"2025","unstructured":"Ye J, Zhong S, Wan H, Guo X, Yao X, Liu Q, et al. Upregulated astrocyte HDAC7 induces Alzheimer-like tau pathologies via deacetylating transcription factor-EB and inhibiting lysosome biogenesis. Mol Neurodegener. 2025;20(1):5.","journal-title":"Mol Neurodegener"},{"issue":"10","key":"897_CR66","doi-asserted-by":"publisher","first-page":"6141","DOI":"10.1007\/s12035-022-02965-6","volume":"59","author":"J Ye","year":"2022","unstructured":"Ye J, Zhong S, Deng Y, Yao X, Liu Q, Wang JZ, et al. HDAC7 Activates IKK\/Nf\u03bab signalling to regulate astrocyte-mediated inflammation. Mol Neurobiol. 2022;59(10):6141\u201357.","journal-title":"Mol Neurobiol"},{"key":"897_CR67","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s12974-025-03603-3","volume":"22","author":"RZ Yue","year":"2025","unstructured":"Yue RZ, Guo X, Li CJ, Wu LJ, Liu YT, Hu J, et al. Upregulated Astrocytic HDAC7 induces depression-like disorders via deacetylating PINK1 and inhibiting mitophagy. J Neuroinflammation. 2025;22:276.","journal-title":"J Neuroinflammation"},{"key":"897_CR68","doi-asserted-by":"crossref","unstructured":"Geng F, Zhao N, Chen X, Liu X, Zhu M, Jiang Y, et al. Transcriptome analysis identifies the role of class I histone deacetylase in Alzheimer\u2019s disease. Heliyon. 2023;9(7):e18008.","DOI":"10.1016\/j.heliyon.2023.e18008"},{"issue":"17","key":"897_CR69","doi-asserted-by":"publisher","first-page":"10014","DOI":"10.3390\/ijms231710014","volume":"23","author":"A Fontana","year":"2022","unstructured":"Fontana A, Cursaro I, Carullo G, Gemma S, Butini S, Campiani G. A Therapeutic perspective of HDAC8 in different diseases: an overview of selective inhibitors. Int J Mol Sci. 2022;23(17):10014.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"897_CR70","doi-asserted-by":"publisher","first-page":"E14573","DOI":"10.1111\/cns.14573","volume":"30","author":"HL Zhang","year":"2024","unstructured":"Zhang HL, Hu S, Yang P, Long HC, Ma QH, Yin DM, et al. HDAC9-mediated calmodulin deacetylation induces memory impairment in Alzheimer\u2019s disease. CNS Neurosci Ther. 2024;30(2):E14573.","journal-title":"CNS Neurosci Ther"},{"key":"897_CR71","doi-asserted-by":"crossref","unstructured":"Lei Y, Chen Y, Guo M, Patel F, Bai Y, Goo B, et al. Neuronal HDAC9: a key regulator of cognitive and synaptic aging, rescuing Alzheimer\u2019s disease-related phenotypes. Mol Psychiatry. 2026;31:4699\u2013715.","DOI":"10.1038\/s41380-026-03556-w"},{"issue":"3","key":"897_CR72","doi-asserted-by":"publisher","first-page":"E14616","DOI":"10.1002\/alz.14616","volume":"21","author":"P Bai","year":"2025","unstructured":"Bai P, Mondal P, Liu Y, Gomm A, Suen C, Yang L, Zhu B, et al. HDAC11 Displays neuropathological alterations and offers as a novel drug target for Alzheimer\u2019s disease. Alzheimers Dement. 2025;21(3):E14616.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"897_CR73","doi-asserted-by":"publisher","first-page":"158","DOI":"10.2174\/1570159X19666210609160017","volume":"20","author":"V Kumar","year":"2022","unstructured":"Kumar V, Kundu S, Singh A, Singh S. Understanding the role of histone deacetylase and their inhibitors in neurodegenerative disorders: Current targets and future perspective. Curr Neuropharmacol. 2022;20(1):158\u201378.","journal-title":"Curr Neuropharmacol"},{"issue":"12","key":"897_CR74","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.3390\/microorganisms10122507","volume":"10","author":"J Fu","year":"2022","unstructured":"Fu J, Zheng Y, Gao Y, Xu W. Dietary fiber intake and gut microbiota in human health. Microorganisms. 2022;10(12):2507.","journal-title":"Microorganisms"},{"key":"897_CR75","doi-asserted-by":"publisher","first-page":"46","DOI":"10.17311\/sciintl.2025.46.57","volume":"13","author":"DC Anih","year":"2025","unstructured":"Anih DC, Adebisi KA, Moses AA, Kenneth CU. Biochemically active metabolites of gut bacteria: Their influence on host metabolism, neurotransmission, and immunity. Sci Int. 2025;13:46\u201357.","journal-title":"Sci Int"},{"key":"897_CR76","doi-asserted-by":"publisher","first-page":"1169624","DOI":"10.3389\/fendo.2023.1169624","volume":"14","author":"KE Masse","year":"2023","unstructured":"Masse KE, Lu VB. Short-chain fatty acids, secondary bile acids and indoles: gut microbial metabolites with effects on enteroendocrine cell function and their potential as therapies for metabolic disease. Front Endocrinol (Lausanne). 2023;14:1169624.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"897_CR77","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.14336\/AD.2022.0104","volume":"13","author":"J Liu","year":"2022","unstructured":"Liu J, Tan Y, Cheng H, Zhang D, Feng W, Peng C. Functions of gut microbiota metabolites, current status and future perspectives. Aging Dis. 2022;13(4):1106.","journal-title":"Aging Dis"},{"issue":"1","key":"897_CR78","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41392-024-01743-1","volume":"9","author":"JS Loh","year":"2024","unstructured":"Loh JS, Mak WQ, Tan LK, Ng CX, Chan HH, Yeow SH, et al. Microbiota\u2013gut\u2013brain axis and its therapeutic applications in neurodegenerative diseases. Signal Transduct Target Ther. 2024;9(1):37. How CW, Khaw KY.","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"897_CR79","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/s41419-021-03880-9","volume":"12","author":"F Zou","year":"2021","unstructured":"Zou F, Qiu Y, Huang Y, Zou H, Cheng X, Niu Q, et al. Effects of short-chain fatty acids in inhibiting HDAC and activating p38 MAPK are critical for promoting B10 cell generation and function. Cell Death Dis. 2021;12(6):582.","journal-title":"Cell Death Dis"},{"issue":"7","key":"897_CR80","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.3390\/biom10071017","volume":"10","author":"C Porro","year":"2020","unstructured":"Porro C, Cianciulli A, Panaro MA. The regulatory role of IL-10 in neurodegenerative diseases. Biomolecules. 2020;10(7):1017.","journal-title":"Biomolecules"},{"issue":"9","key":"897_CR81","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.jnutbio.2007.08.002","volume":"19","author":"M Waldecker","year":"2008","unstructured":"Waldecker M, Kautenburger T, Daumann H, Busch C, Schrenk D. Inhibition of histone-deacetylase activity by short-chain fatty acids and some polyphenol metabolites formed in the colon. J Nutr Biochem. 2008;19(9):587\u201393.","journal-title":"J Nutr Biochem"},{"issue":"1","key":"897_CR82","doi-asserted-by":"publisher","first-page":"2105637","DOI":"10.1080\/19490976.2022.2105637","volume":"14","author":"M Modoux","year":"2022","unstructured":"Modoux M, Rolhion N, Lefevre JH, Oeuvray C, N\u00e1dvorn\u00edk P, Illes P, et al. Butyrate acts through hdac inhibition to enhance aryl hydrocarbon receptor activation by gut microbiota-derived ligands. Gut Microbes. 2022;14(1):2105637.","journal-title":"Gut Microbes"},{"issue":"18","key":"897_CR83","doi-asserted-by":"publisher","first-page":"6777","DOI":"10.3390\/ijms21186777","volume":"21","author":"M Choudhary","year":"2020","unstructured":"Choudhary M, Malek G. The aryl hydrocarbon receptor: a mediator and potential therapeutic target for ocular and non-ocular neurodegenerative diseases. Int J Mol Sci. 2020;21(18):6777.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"897_CR84","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.3390\/biomedicines11092587","volume":"11","author":"BS Sivamaruthi","year":"2023","unstructured":"Sivamaruthi BS, Raghani N, Chorawala M, Bhattacharya S, Prajapati BG, Elossaily GM, et al. Nf\u03bab pathway and its inhibitors: a promising frontier in the management of Alzheimer\u2019s disease. Biomedicines. 2023;11(9):2587.","journal-title":"Biomedicines"},{"issue":"18","key":"897_CR85","doi-asserted-by":"publisher","first-page":"8797","DOI":"10.7150\/thno.61601","volume":"11","author":"C Qian","year":"2021","unstructured":"Qian C, Yang C, Lu M, Bao J, Shen H, Deng B, et al. Activating AHR alleviates cognitive deficits of Alzheimer\u2019s disease model mice by upregulating endogenous a\u03b2 catabolic enzyme neprilysin. Theranostics. 2021;11(18):8797.","journal-title":"Theranostics"},{"key":"897_CR86","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.biochi.2021.04.011","volume":"186","author":"MK Ediriweera","year":"2021","unstructured":"Ediriweera MK, To NB, Lim Y, Cho SK. Odd-chain fatty acids as novel histone deacetylase 6 (HDAC6) inhibitors. Biochimie. 2021;186:147\u201356.","journal-title":"Biochimie"},{"issue":"5","key":"897_CR87","doi-asserted-by":"publisher","first-page":"793","DOI":"10.3390\/cells12050793","volume":"12","author":"J Wang","year":"2023","unstructured":"Wang J, Zhu N, Su X, Gao Y, Yang R. Gut-microbiota-derived metabolites maintain gut and systemic immune homeostasis. Cells. 2023;12(5):793.","journal-title":"Cells"},{"issue":"3","key":"897_CR88","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/advances\/nmz127","volume":"11","author":"K Gao","year":"2020","unstructured":"Gao K, Mu CL, Farzi A, Zhu WY. Tryptophan metabolism: a link between the gut microbiota and brain. Adv Nutr. 2020;11(3):709\u201323.","journal-title":"Adv Nutr"},{"issue":"1","key":"897_CR89","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s12035-025-05538-5","volume":"63","author":"C Shi","year":"2026","unstructured":"Shi C, Dong J, Hui X, Xu Z, Zhao Z, Dong L. Production, mechanisms, and therapeutic strategies of tryptophan metabolites in CNS diseases. Mol Neurobiol. 2026;63(1):226.","journal-title":"Mol Neurobiol"},{"issue":"4","key":"897_CR90","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.bbrc.2019.07.074","volume":"517","author":"S Mimori","year":"2019","unstructured":"Mimori S, Kawada K, Saito R, Takahashi M, Mizoi K, Okuma Y, Hosokawa M, et al. Indole-3-propionic acid has chemical chaperone activity and suppresses endoplasmic reticulum stress-induced neuronal cell death. Biochem Biophys Res Commun. 2019;517(4):623\u20138.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"897_CR91","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1080\/14756366.2020.1870457","volume":"36","author":"Y Chen","year":"2021","unstructured":"Chen Y, Zhang L, Zhang L, Jiang Q, Zhang L. Discovery of indole-3-butyric acid derivatives as potent histone deacetylase inhibitors. J Enzyme Inhib Med Chem. 2021;36(1):425\u201336.","journal-title":"J Enzyme Inhib Med Chem"},{"key":"897_CR92","doi-asserted-by":"publisher","first-page":"113893","DOI":"10.1016\/j.ejmech.2021.113893","volume":"227","author":"BE Jiang","year":"2022","unstructured":"Jiang BE, Hu J, Liu H, Liu Z, Wen Y, Liu M, et al. Design, synthesis, and biological evaluation of indole-based hydroxamic acid derivatives as histone deacetylase inhibitors. Eur J Med Chem. 2022;227:113893.","journal-title":"Eur J Med Chem"},{"issue":"19","key":"897_CR93","doi-asserted-by":"publisher","first-page":"4770","DOI":"10.3390\/molecules29194770","volume":"29","author":"X Mo","year":"2024","unstructured":"Mo X, Rao DP, Kaur K, Hassan R, Abdel-Samea AS, Farhan SM, et al. Indole derivatives: A versatile scaffold in modern drug discovery\u2014an updated review on their multifaceted therapeutic applications (2020\u20132024). Molecules. 2024;29(19):4770.","journal-title":"Molecules"},{"issue":"9","key":"897_CR94","doi-asserted-by":"publisher","first-page":"2200739","DOI":"10.1002\/mnfr.202200739","volume":"67","author":"J Yin","year":"2023","unstructured":"Yin J, Zhang Y, Liu X, Li W, Hu Y, Zhang B, et al. Gut microbiota-derived indole derivatives alleviate neurodegeneration in aging through activating GPR30\/AMPK\/SIRT1 pathway. Mol Nutr Food Res. 2023;67(9):2200739.","journal-title":"Mol Nutr Food Res"},{"issue":"19","key":"897_CR95","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.3390\/foods14193299","volume":"14","author":"D Gutierres","year":"2025","unstructured":"Gutierres D, Pacheco R, Reis CP. The role of omega-3 and omega-6 polyunsaturated fatty acid supplementation in human health. Foods. 2025;14(19):3299.","journal-title":"Foods"},{"issue":"11","key":"897_CR96","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1093\/jnen\/nlae094","volume":"83","author":"L He","year":"2024","unstructured":"He L, Ye J, Zhuang X, Shi J, Wu W. Omega-3 Polyunsaturated fatty acids alleviate endoplasmic reticulum stress-induced neuroinflammation by protecting against traumatic spinal cord injury through the histone deacetylase 3\/peroxisome proliferator-activated receptor-\u03b3 coactivator pathway. J Neuropathol Exp Neurol. 2024;83(11):939\u201350.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"13","key":"897_CR97","doi-asserted-by":"publisher","first-page":"10717","DOI":"10.3390\/ijms241310717","volume":"24","author":"C Kousparou","year":"2023","unstructured":"Kousparou C, Fyrilla M, Stephanou A, Patrikios I, DHA\/EPA. (Omega-3) And LA\/GLA (Omega-6) as bioactive molecules in neurodegenerative diseases. Int J Mol Sci. 2023;24(13):10717.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"897_CR98","first-page":"6360487","volume":"2023","author":"MK Ediriweera","year":"2023","unstructured":"Ediriweera MK. The histone deacetylase inhibitory potential of chicken egg yolk fat and their fatty acid composition. Scientifica. 2023;2023(1):6360487.","journal-title":"Scientifica"},{"issue":"5","key":"897_CR99","doi-asserted-by":"publisher","first-page":"103569","DOI":"10.1016\/j.drudis.2023.103569","volume":"28","author":"MK Ediriweera","year":"2023","unstructured":"Ediriweera MK. Fatty acids as histone deacetylase inhibitors: old biochemistry tales in a new life sciences town. Drug Discov Today. 2023;28(5):103569.","journal-title":"Drug Discov Today"},{"issue":"8","key":"897_CR100","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1271\/bbb.70068","volume":"71","author":"N Aburai","year":"2007","unstructured":"Aburai N, Esumi Y, Koshino H, Nishizawa N, Kimura KI. Inhibitory activity of linoleic acid isolated from proso and Japanese millet toward histone deacetylase. Biosci Biotechnol Biochem. 2007;71(8):2061\u20134.","journal-title":"Biosci Biotechnol Biochem"},{"issue":"1","key":"897_CR101","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1146\/annurev-physiol-020518-114455","volume":"81","author":"M Neinast","year":"2019","unstructured":"Neinast M, Murashige D, Arany Z. Branched chain amino acids. Annu Rev Physiol. 2019;81(1):139\u201364.","journal-title":"Annu Rev Physiol"},{"issue":"21","key":"897_CR102","doi-asserted-by":"publisher","first-page":"3523","DOI":"10.3390\/cells11213523","volume":"11","author":"MA Siddik","year":"2022","unstructured":"Siddik MA, Mullins CA, Kramer A, Shah H, Gannaban RB, Zabet-Moghaddam M, et al. Branched-chain amino acids are linked with Alzheimer\u2019s disease-related pathology and cognitive deficits. Cells. 2022;11(21):3523.","journal-title":"Cells"},{"issue":"7","key":"897_CR103","doi-asserted-by":"publisher","first-page":"4022","DOI":"10.3390\/ijms23074022","volume":"23","author":"A Dimou","year":"2022","unstructured":"Dimou A, Tsimihodimos V, Bairaktari E. The critical role of the branched-chain amino acids (BCAA) catabolism-regulating enzymes, branched-chain aminotransferase (BCAT) and branched-chain \u03b1-keto acid dehydrogenase (BCKD), in human pathophysiology. Int J Mol Sci. 2022;23(7):4022.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"897_CR104","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s11011-020-00631-1","volume":"36","author":"EL Streck","year":"2021","unstructured":"Streck EL, Bussular FP, Wessler LB, Duarte MB, Rezende VL, Rodrigues MS, et al. Administration of branched-chain amino acids alters epigenetic regulatory enzymes in an animal model of maple syrup urine disease. Metab Brain Dis. 2021;36(2):247\u201354.","journal-title":"Metab Brain Dis"},{"issue":"1","key":"897_CR105","doi-asserted-by":"publisher","first-page":"134","DOI":"10.2174\/18755739MTEzaMDMw2","volume":"18","author":"K Maiese","year":"2021","unstructured":"Maiese K. Nicotinamide as a foundation for treating neurodegenerative disease and metabolic disorders. Curr Neurovasc Res. 2021;18(1):134\u201349.","journal-title":"Curr Neurovasc Res"},{"issue":"1","key":"897_CR106","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/jnc.14599","volume":"148","author":"IF Harrison","year":"2019","unstructured":"Harrison IF, Powell NM, Dexter DT. The histone deacetylase inhibitor nicotinamide exacerbates neurodegeneration in the lactacystin rat model of Parkinson\u2019s disease. J Neurochem. 2019;148(1):136\u201356.","journal-title":"J Neurochem"},{"issue":"18","key":"897_CR107","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1007\/s00018-017-2527-8","volume":"74","author":"ES Hwang","year":"2017","unstructured":"Hwang ES, Song SB. Nicotinamide is an inhibitor of SIRT1 in vitro, but can be a stimulator in cells. Cell Mol Life Sci. 2017;74(18):3347\u201362.","journal-title":"Cell Mol Life Sci"},{"issue":"45","key":"897_CR108","doi-asserted-by":"publisher","first-page":"11500","DOI":"10.1523\/JNEUROSCI.3203-08.2008","volume":"28","author":"KN Green","year":"2008","unstructured":"Green KN, Steffan JS, Martinez-Coria H, Sun X, Schreiber SS, Thompson LM, Laferla FM. Nicotinamide restores cognition in Alzheimer\u2019s disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau. J Neurosci. 2008;28(45):11500\u201310.","journal-title":"J Neurosci"},{"issue":"1","key":"897_CR109","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","volume":"24","author":"A Wahlstr\u00f6m","year":"2016","unstructured":"Wahlstr\u00f6m A, Sayin SI, Marschall HU, B\u00e4ckhed F. Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell Metab. 2016;24(1):41\u201350.","journal-title":"Cell Metab"},{"issue":"23","key":"897_CR110","doi-asserted-by":"publisher","first-page":"11301","DOI":"10.3390\/ijms262311301","volume":"26","author":"EL Butcher","year":"2025","unstructured":"Butcher EL, Arthur S. Emerging roles of bile acids in neuroinflammation. Int J Mol Sci. 2025;26(23):11301.","journal-title":"Int J Mol Sci"},{"key":"897_CR111","doi-asserted-by":"crossref","unstructured":"Pei X, Wang X, Lu H, Wu J, Xu L, Chen X, et al. Effects of bile acids and gut microbiota interactions on neurological and psychiatric disorders. Genes Dis. 2026;102069.","DOI":"10.1016\/j.gendis.2026.102069"},{"issue":"1","key":"897_CR112","doi-asserted-by":"publisher","first-page":"2422468","DOI":"10.1080\/19490976.2024.2422468","volume":"16","author":"MU Munir","year":"2024","unstructured":"Munir MU, Ali SA, Chung KH, Kakinen A, Javed I, Davis TP. Reverse engineering the gut-brain axis and microbiome-metabolomics for symbiotic\/pathogenic balance in neurodegenerative diseases. Gut Microbes. 2024;16(1):2422468.","journal-title":"Gut Microbes"},{"key":"897_CR113","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.bbi.2023.11.021","volume":"115","author":"F Zhang","year":"2024","unstructured":"Zhang F, Deng Y, Wang H, Fu J, Wu G, Duan Z, Zhang X, Cai Y, Zhou H, Yin J, He Y. Gut microbiota-mediated ursodeoxycholic acids regulate the inflammation of microglia through TGR5 signalling after MCAO. Brain Behav Immun. 2024;115:667\u201379.","journal-title":"Brain Behav Immun"},{"issue":"22","key":"897_CR114","doi-asserted-by":"publisher","first-page":"3650","DOI":"10.3390\/cells11223650","volume":"11","author":"Y Deng","year":"2022","unstructured":"Deng Y, Zou J, Hong Y, Peng Q, Fu X, Duan R, Chen J, Chen X. Higher circulating trimethylamine N-oxide aggravates cognitive impairment probably via downregulating hippocampal SIRT1 in vascular dementia rats. Cells. 2022;11(22):3650.","journal-title":"Cells"},{"key":"897_CR115","doi-asserted-by":"publisher","first-page":"1499591","DOI":"10.3389\/fnmol.2024.1499591","volume":"17","author":"S Zhu","year":"2024","unstructured":"Zhu S, Wang Y, Li Y, Li N, Zheng Y, Li Q, et al. TMAO is involved in sleep deprivation-induced cognitive dysfunction through regulating astrocytic cholesterol metabolism via SREBP2. Front Mol Neurosci. 2024;17:1499591.","journal-title":"Front Mol Neurosci"},{"issue":"19","key":"897_CR116","doi-asserted-by":"publisher","first-page":"8642","DOI":"10.18632\/aging.102352","volume":"11","author":"Q Gao","year":"2019","unstructured":"Gao Q, Wang Y, Wang X, Fu S, Zhang X, Wang RT. Decreased levels of circulating trimethylamine n-oxide alleviate cognitive and pathological deterioration in transgenic mice: A potential therapeutic approach for Alzheimer\u2019s disease. Aging. 2019;11(19):8642.","journal-title":"Aging"},{"issue":"1","key":"897_CR117","doi-asserted-by":"publisher","first-page":"628","DOI":"10.18632\/aging.102645","volume":"12","author":"QJ Wang","year":"2020","unstructured":"Wang QJ, Shen YE, Wang X, Fu S, Zhang X, Zhang YN, Wang RT. Concomitant memantine and lactobacillus plantarum treatment attenuates cognitive impairments in APP\/PS1 mice. Aging. 2020;12(1):628.","journal-title":"Aging"},{"issue":"1","key":"897_CR118","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/s41522-025-00810-x","volume":"11","author":"E Grundeken","year":"2025","unstructured":"Grundeken E, El Aidy S, Enteroendocrine, Cells. The gatekeepers of microbiome-gut-brain communication. NPJ Biofilms Microbiomes. 2025;11(1):179.","journal-title":"NPJ Biofilms Microbiomes"},{"issue":"5","key":"897_CR119","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1111\/nmo.12754","volume":"28","author":"R Latorre","year":"2016","unstructured":"Latorre R, Sternini C, De Giorgio R, Greenwood-Van Meerveld B. Enteroendocrine cells: A review of their role in brain\u2013gut communication. Neurogastroenterol Motil. 2016;28(5):620\u201330.","journal-title":"Neurogastroenterol Motil"},{"issue":"11","key":"897_CR120","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1210\/me.2015-1184","volume":"29","author":"L Ma","year":"2015","unstructured":"Ma L, Tang H, Yin Y, Yu R, Zhao J, Li Y, et al. HDAC5-mTORC1 interaction in differential regulation of ghrelin and nucleobindin 2 (NUCB2)\/Nesfatin-1. Mol Endocrinol. 2015;29(11):1571\u201380.","journal-title":"Mol Endocrinol"},{"key":"897_CR121","first-page":"052","volume":"3","author":"I Ebule","year":"2017","unstructured":"Ebule I, Djune F, Njeambosay B, Doh G, Befolo MH. Atrophic gastritis and gastric cancer risk amongst diabetes mellitus type 2 subjects and controls in Yaounde, Cameroon using a panel of serum biomarkers (PGI, G-17). J Clin Gastroenterol Treat. 2017;3:052.","journal-title":"J Clin Gastroenterol Treat"},{"issue":"4","key":"897_CR122","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.cmet.2024.02.007","volume":"36","author":"D Guan","year":"2024","unstructured":"Guan D, Men Y, Bartlett A, Hern\u00e1ndez MA, Xu J, Yi X, et al. Central inhibition of HDAC6 re-sensitizes leptin signalling during obesity to induce profound weight loss. Cell Metab. 2024;36(4):857\u201376.","journal-title":"Cell Metab"},{"issue":"1","key":"897_CR123","doi-asserted-by":"publisher","first-page":"10782","DOI":"10.1038\/ncomms10782","volume":"7","author":"DG Kabra","year":"2016","unstructured":"Kabra DG, Pfuhlmann K, Garcia CC, Schriever SC, Casquero Garcia V, Kebede AF, et al. Hypothalamic leptin action is mediated by histone deacetylase 5. Nat Commun. 2016;7(1):10782.","journal-title":"Nat Commun"},{"issue":"6","key":"897_CR124","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s10517-019-04608-8","volume":"167","author":"GN Zyuz\u2019kov","year":"2019","unstructured":"Zyuz\u2019kov GN, Miroshnichenko LA, Polyakova TY, Stavrova LA, Simanina EV, Agafonov VI, et al. Participation of Camp\/PKA-mediated signalling pathways in functional activity of regeneration-competent cells in the nervous tissue under conditions of ethanol-induced neurodegeneration. Bull Exp Biol Med. 2019;167(6):723\u20137.","journal-title":"Bull Exp Biol Med"},{"issue":"1","key":"897_CR125","first-page":"158","volume":"8","author":"SM Atya","year":"2024","unstructured":"Atya SM. Camp\/PKA-CREB-BDNF signalling cascade and phosphodiesterase 4 inhibition: A possible neuroprotective approach in Alzheimer\u2019s disease. Rec Pharm Biomed Sci. 2024;8(1):158\u201368.","journal-title":"Rec Pharm Biomed Sci"},{"key":"897_CR126","doi-asserted-by":"publisher","first-page":"101122","DOI":"10.1016\/j.yfrne.2024.101122","volume":"73","author":"N Reich","year":"2024","unstructured":"Reich N, H\u00f6lscher C. Cholecystokinin (CCK): A neuromodulator with therapeutic potential in Alzheimer\u2019s and Parkinson\u2019s disease. Front Neuroendocrinol. 2024;73:101122.","journal-title":"Front Neuroendocrinol"},{"issue":"1","key":"897_CR127","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.surg.2019.05.092","volume":"167","author":"R Guenter","year":"2020","unstructured":"Guenter R, Aweda T, Matos DM, Jang S, Whitt J, Cheng YQ, et al. Overexpression of somatostatin receptor type 2 in neuroendocrine tumors for improved Ga68-DOTATATE imaging and treatment. Surgery. 2020;167(1):189\u201396.","journal-title":"Surgery"},{"issue":"3","key":"897_CR128","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s11154-020-09607-z","volume":"22","author":"MJ Klomp","year":"2021","unstructured":"Klomp MJ, Dalm SU, De Jong M, Feelders RA, Hofland J, Hofland LJ. Epigenetic regulation of somatostatin and somatostatin receptors in neuroendocrine tumors and other types of cancer. Rev Endocr Metab Disord. 2021;22(3):495\u2013510.","journal-title":"Rev Endocr Metab Disord"},{"key":"897_CR129","unstructured":"Kastin A. Handbook of biologically active peptides. Academic; 2013."},{"key":"897_CR130","first-page":"351","volume":"20","author":"CH Lscher","year":"2012","unstructured":"Lscher CH. Roles of Glucagon-Like Peptide and Glucose-Dependent Insulinotropic Polypeptide Hormones in Brain Function and neurodegeneration. Therapeutic Targets: Modulation Inhib Activation. 2012;20:351.","journal-title":"Therapeutic Targets: Modulation Inhib Activation"},{"issue":"2","key":"897_CR131","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00125-008-1202-x","volume":"52","author":"HE Parker","year":"2009","unstructured":"Parker HE, Habib AM, Rogers GJ, Gribble FM, Reimann F. Nutrient-dependent secretion of glucose-dependent insulinotropic polypeptide from primary murine K cells. Diabetologia. 2009;52(2):289\u201398.","journal-title":"Diabetologia"},{"issue":"5","key":"897_CR132","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1111\/bph.12352","volume":"170","author":"S Joshi","year":"2013","unstructured":"Joshi S, Tough IR, Cox HM. Endogenous PYY and GLP-1 mediate L\u2010glutamine responses in intestinal mucosa. Br J Pharmacol. 2013;170(5):1092\u2013101.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"897_CR133","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12964-020-00569-y","volume":"18","author":"S Nikolaou","year":"2020","unstructured":"Nikolaou S, Qiu S, Fiorentino F, Simillis C, Rasheed S, Tekkis P, et al. The role of neurotensin and its receptors in non-gastrointestinal cancers: A review. Cell Commun Signal. 2020;18(1):68.","journal-title":"Cell Commun Signal"},{"key":"897_CR134","doi-asserted-by":"publisher","first-page":"E52212","DOI":"10.7554\/eLife.52212","volume":"9","author":"S Bele","year":"2020","unstructured":"Bele S, Girada SB, Ray A, Gupta A, Oruganti S, Prakash Babu P, et al. MS-275, A class 1 histone deacetylase inhibitor augments glucagon-like peptide-1 receptor agonism to improve glycemic control and reduce obesity in diet-induced obese mice. Elife. 2020;9:E52212.","journal-title":"Elife"},{"issue":"5","key":"897_CR135","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1136\/gut.26.5.518","volume":"26","author":"BM Miazza","year":"1985","unstructured":"Miazza BM, Al-Mukhtar MY, Salmeron M, Ghatei MA, Felce-Dachez M, Filali A, et al. Hyperenteroglucagonaemia and small intestinal mucosal growth after colonic perfusion of glucose in rats. Gut. 1985;26(5):518\u201324.","journal-title":"Gut"},{"issue":"3","key":"897_CR136","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1681\/ASN.2005080818","volume":"17","author":"A Sin\u0111ic","year":"2006","unstructured":"Sin\u0111ic A, Schlatter E. Cellular effects of guanylin and uroguanylin. J Am Soc Nephrol. 2006;17(3):607\u201316.","journal-title":"J Am Soc Nephrol"},{"key":"897_CR137","doi-asserted-by":"crossref","unstructured":"Gargantini E, Lazzari L, Settanni F, Taliano M, Trovato L, Gesmundo I, et al. Obestatin promotes proliferation and survival of adult hippocampal progenitors and reduces amyloid-\u03b2-induced toxicity. Mol Cell Endocrinol. 2016;422:18-30.4.","DOI":"10.1016\/j.mce.2015.11.008"},{"key":"897_CR138","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.mcn.2016.09.003","volume":"77","author":"S Shukla","year":"2016","unstructured":"Shukla S, Shariat-Madar Z, Walker LA, Tekwani BL. Mechanism for neurotropic action of vorinostat, a pan histone deacetylase inhibitor. Mol Cell Neurosci. 2016;77:11\u201320.","journal-title":"Mol Cell Neurosci"},{"key":"897_CR139","doi-asserted-by":"publisher","first-page":"118861","DOI":"10.1016\/j.biopha.2025.118861","volume":"193","author":"T Taj","year":"2025","unstructured":"Taj T, Kaushik M, Islam A, Das J, Kumar B, Hussain MS, et al. Microbiota-brain interaction: The role of gut-derived proteins in addressing various neurological disorders including Parkinson\u2019s and Alzheimer\u2019s diseases. Biomed Pharmacother. 2025;193:118861.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"897_CR140","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11011-026-01798-9","volume":"41","author":"ZB Altan","year":"2026","unstructured":"Altan ZB, Ihlamur M. The relationship between gut microbiota and neurodegenerative diseases: a genetic and epigenetic perspective. Metab Brain Dis. 2026;41(1):43.","journal-title":"Metab Brain Dis"},{"key":"897_CR141","doi-asserted-by":"crossref","unstructured":"Spiridon IA, Ciobanu DG, Giu\u0219c\u0103 SE, C\u0103runtu ID. Ghrelin and its role in gastrointestinal tract tumors. Mol Med Rep. 202;24(3):663.","DOI":"10.3892\/mmr.2021.12302"},{"issue":"38","key":"897_CR142","doi-asserted-by":"publisher","first-page":"6773","DOI":"10.2174\/13816128113199990411","volume":"19","author":"V Dos Santos","year":"2013","unstructured":"Dos Santos V, Rodrigues AL, De LT, Barioglio S, Raisman-Vozari R, Prediger R. Ghrelin as a neuroprotective and palliative agent in Alzheimer\u2019s and Parkinson\u2019s disease. Curr Pharm Des. 2013;19(38):6773\u201390.","journal-title":"Curr Pharm Des"},{"key":"897_CR143","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.neubiorev.2016.12.010","volume":"73","author":"Q Jiao","year":"2017","unstructured":"Jiao Q, Du X, Li Y, Gong B, Shi L, Tang T, et al. The neurological effects of ghrelin in brain diseases: beyond metabolic functions. Neurosci Biobehav Rev. 2017;73:98\u2013111.","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"897_CR144","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3233\/JAD-2010-101263","volume":"23","author":"M Moon","year":"2011","unstructured":"Moon M, Choi JG, Nam DW, Hong HS, Choi YJ, Oh MS, et al. Ghrelin ameliorates cognitive dysfunction and neurodegeneration in intrahippocampal amyloid-\u03b21\u201342 oligomer-injected mice. J Alzheimers Dis. 2011;23(1):147\u201359.","journal-title":"J Alzheimers Dis"},{"key":"897_CR145","doi-asserted-by":"crossref","unstructured":"Jeon SG, Hong SB, Nam Y, Tae J, Yoo A, Song EJ, Moon M, Choi JG, Nam DW, Hong HS, Choi YJ, Oh MS, et al. Ghrelin in Alzheimer\u2019s disease: pathologic roles and therapeutic implications. Ageing Res RevJ Alzheimers Dis. 2019;55:100945.","DOI":"10.1016\/j.arr.2019.100945"},{"issue":"7","key":"897_CR146","doi-asserted-by":"publisher","first-page":"E21368","DOI":"10.1096\/fj.202001584R","volume":"35","author":"B Li","year":"2021","unstructured":"Li B, Zhang L, Zhu L, Cao Y, Dou Z, Yu Q. HDAC5 Promotes intestinal sepsis via the ghrelin\/E2F1\/NF-\u039ab axis. FASEB J. 2021;35(7):E21368.","journal-title":"FASEB J"},{"key":"897_CR147","doi-asserted-by":"publisher","first-page":"E10473","DOI":"10.7554\/eLife.10473","volume":"5","author":"JM Ankers","year":"2016","unstructured":"Ankers JM, Awais R, Jones NA, Boyd J, Ryan S, Adamson AD, et al. Dynamic Nf\u03bab and E2F interactions control the priority and timing of inflammatory signalling and cell proliferation. Elife. 2016;5:E10473.","journal-title":"Elife"},{"key":"897_CR148","doi-asserted-by":"publisher","first-page":"378","DOI":"10.3389\/fnins.2019.00378","volume":"13","author":"X Zou","year":"2019","unstructured":"Zou X, Zhong L, Zhu C, Zhao H, Zhao F, Cui R, et al. Role of leptin in mood disorder and neurodegenerative disease. Front Neurosci. 2019;13:378.","journal-title":"Front Neurosci"},{"issue":"9","key":"897_CR149","doi-asserted-by":"publisher","first-page":"5849","DOI":"10.1002\/alz.13879","volume":"20","author":"S Charisis","year":"2024","unstructured":"Charisis S, Short MI, Bernal R, Kautz TF, Trevino HA, Mathews J, et al. Leptin bioavailability and markers of brain atrophy and vascular injury in the middle age. Alzheimer\u2019s Dement. 2024;20(9):5849\u201360.","journal-title":"Alzheimer\u2019s Dement"},{"key":"897_CR150","doi-asserted-by":"publisher","first-page":"176490","DOI":"10.1016\/j.ejphar.2024.176490","volume":"970","author":"SP Panda","year":"2024","unstructured":"Panda SP, Kesharwani A, Datta S, Prasanth DS, Panda SK, Guru A. JAK2\/STAT3 as a new potential target to manage neurodegenerative diseases: An interactive review. Eur J Pharmacol. 2024;970:176490.","journal-title":"Eur J Pharmacol"},{"key":"897_CR151","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.neubiorev.2021.10.009","volume":"131","author":"JD Iroegbu","year":"2021","unstructured":"Iroegbu JD, Ijomone OK, Femi-Akinlosotu OM, Ijomone OM. ERK\/MAPK signalling in the developing brain: Perturbations and consequences. Neurosci Biobehav Rev. 2021;131:792\u2013805.","journal-title":"Neurosci Biobehav Rev"},{"issue":"12","key":"897_CR152","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.3390\/ijms21124471","volume":"21","author":"HA Gasco","year":"2020","unstructured":"Gasco HA, Ros-Bernal FR, Castillo-G\u00f3mez ES, Olucha-Bordonau F. MAPK\/ERK dysfunction in neurodegenerative diseases. Int J Mol Sci. 2020;21(12):4471.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"897_CR153","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s12192-021-01231-3","volume":"26","author":"E Razani","year":"2021","unstructured":"Razani E, Pourbagheri-Sigaroodi A, Safaroghli-Azar A, Zoghi A, Shanaki-Bavarsad M, Bashash D. The PI3K\/Akt signalling axis in Alzheimer\u2019s disease: A valuable target to stimulate or suppress. Cell Stress Chaperones. 2021;26(6):871\u201387.","journal-title":"Cell Stress Chaperones"},{"issue":"21","key":"897_CR154","doi-asserted-by":"publisher","first-page":"11638","DOI":"10.3390\/ijms252111638","volume":"25","author":"B Wright","year":"2024","unstructured":"Wright B, King S, Suphioglu C. The importance of phosphoinositide 3-kinase in neuroinflammation. Int J Mol Sci. 2024;25(21):11638.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"897_CR155","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s42255-021-00515-3","volume":"4","author":"I \u00c7ak\u0131r","year":"2022","unstructured":"\u00c7ak\u0131r I, Hadley CK, Pan PL, Bagchi RA, Ghamari-Langroudi M, Porter DT, Wang Q, Litt MJ, Jana S, Hagen S, Lee P. Histone deacetylase 6 inhibition restores leptin sensitivity and reduces obesity. Nat Metabolism. 2022;4(1):44\u201359.","journal-title":"Nat Metabolism"},{"issue":"8","key":"897_CR156","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/S0898-6568(02)00006-2","volume":"14","author":"G Sweeney","year":"2002","unstructured":"Sweeney G. Leptin Signalling. Cell Signal. 2002;14(8):655\u201363.","journal-title":"Cell Signal"},{"issue":"1","key":"897_CR157","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12929-024-01090-x","volume":"31","author":"CT Hong","year":"2024","unstructured":"Hong CT, Chen JH, Hu CJ. Role of glucagon-like peptide-1 receptor agonists in Alzheimer\u2019s disease and Parkinson\u2019s disease. J Biomed Sci. 2024;31(1):102.","journal-title":"J Biomed Sci"},{"key":"897_CR158","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.3389\/fnins.2019.01112","volume":"13","author":"M Grieco","year":"2019","unstructured":"Grieco M, Giorgi A, Gentile MC, Erme M, Morano S, Maras B, et al. Glucagon-like peptide-1: A focus on neurodegenerative diseases. Front Neurosci. 2019;13:1112.","journal-title":"Front Neurosci"},{"key":"897_CR159","doi-asserted-by":"publisher","first-page":"106550","DOI":"10.1016\/j.phrs.2022.106550","volume":"186","author":"KO Kopp","year":"2022","unstructured":"Kopp KO, Glotfelty EJ, Li Y, Greig NH. Glucagon like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment. Pharmacol Res. 2022;186:106550.","journal-title":"Pharmacol Res"},{"key":"897_CR160","doi-asserted-by":"crossref","unstructured":"Zhou ZD, Yi L, Pop\u0142awska-Domaszewicz K, Chaudhuri KR, Jankovic J, Tan EK. Glucagon-like peptide-1 receptor agonists in neurodegenerative diseases: promises and challenges. Pharmacol Res. 2025;216:107770.","DOI":"10.1016\/j.phrs.2025.107770"},{"issue":"19","key":"897_CR161","doi-asserted-by":"publisher","first-page":"12896","DOI":"10.1074\/jbc.M809046200","volume":"284","author":"SJ Kim","year":"2009","unstructured":"Kim SJ, Nian C, Mcintosh CH. Glucose dependent insulinotropic polypeptide and glucagon-like peptide-1 modulate \u03b2-cell chromatin structure. J Biol Chem. 2009;284(19):12896\u2013904.","journal-title":"J Biol Chem"},{"key":"897_CR162","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.neurobiolaging.2019.01.002","volume":"76","author":"A Plagman","year":"2019","unstructured":"Plagman A, Hoscheidt S, Mclimans KE, Klinedinst B, Pappas C, Anantharam V, et al. Alzheimer\u2019s disease neuroimaging initiative. Cholecystokinin And Alzheimer\u2019s Disease: A biomarker of metabolic function, neural integrity, and cognitive performance. Neurobiol Aging. 2019;76:201\u20137. Willette AA.","journal-title":"Neurobiol Aging"},{"key":"897_CR163","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/978-3-319-43589-3_7","volume":"107","author":"M Domise","year":"2016","unstructured":"Domise M, Vingtdeux V. AMPK in neurodegenerative diseases. AMP-activated protein kinase Exp Suppl. 2016;107:153\u201377.","journal-title":"AMP-activated protein kinase Exp Suppl"},{"key":"897_CR164","doi-asserted-by":"publisher","first-page":"106248","DOI":"10.1016\/j.fbio.2025.106248","volume":"66","author":"J Park","year":"2025","unstructured":"Park J, Moon CY, Jo J, Kang H. Protective effects of ginsenoside Rd on inflammation and mitochondrial dysfunction in lipopolysaccharide-induced microglial activation through histone deacetylase 5-mediated signalling. Food Biosci. 2025;66:106248.","journal-title":"Food Biosci"},{"issue":"2","key":"897_CR165","doi-asserted-by":"publisher","first-page":"382","DOI":"10.14283\/jpad.2024.6","volume":"11","author":"L Hao","year":"2024","unstructured":"Hao L, Shi M, Ma J, Shao S, Yuan Y, Liu J, et al. A cholecystokinin analogue ameliorates cognitive deficits and regulates mitochondrial dynamics via the AMPK\/Drp1 pathway in APP\/PS1 mice. J Prev Alzheimer\u2019s Dis. 2024;11(2):382\u2013401.","journal-title":"J Prev Alzheimer\u2019s Dis"},{"key":"897_CR166","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3389\/fnins.2020.00387","volume":"14","author":"L Wang","year":"2020","unstructured":"Wang L, Zhang L. Involvement of secretin in the control of cell survival and synaptic plasticity in the central nervous system. Front Neurosci. 2020;14:387.","journal-title":"Front Neurosci"},{"issue":"5","key":"897_CR167","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1093\/hmg\/ddq545","volume":"20","author":"PI Jukkola","year":"2011","unstructured":"Jukkola PI, Rogers JT, Kaspar BK, Weeber EJ, Nishijima I. Secretin deficiency causes impairment in survival of neural progenitor cells in mice. Hum Mol Genet. 2011;20(5):1000\u20137.","journal-title":"Hum Mol Genet"},{"key":"897_CR168","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3389\/fncel.2017.00382","volume":"11","author":"L Wang","year":"2017","unstructured":"Wang L, Zhang L, Chow BK. Secretin modulates the postnatal development of mouse cerebellar cortex via PKA and ERK dependent pathways. Front Cell Neurosci. 2017;11:382.","journal-title":"Front Cell Neurosci"},{"issue":"10","key":"897_CR169","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1073\/pnas.84.10.3146","volume":"84","author":"ER Trimble","year":"1987","unstructured":"Trimble ER, Bruzzone R, Biden TJ, Meehan CJ, Andreu D, Merrifield RB. Secretin stimulates cyclic AMP and inositol trisphosphate production in rat pancreatic acinar tissue by two fully independent mechanisms. Proc Natl Acad Sci USA. 1987;84(10):3146\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"key":"897_CR170","doi-asserted-by":"publisher","first-page":"118020","DOI":"10.1016\/j.lfs.2020.118020","volume":"257","author":"M Amidfar","year":"2020","unstructured":"Amidfar M, De Oliveira J, Kucharska E, Budni J, Kim YK. The role of CREB and BDNF in neurobiology and treatment of Alzheimer\u2019s disease. Life Sci. 2020;257:118020.","journal-title":"Life Sci"},{"issue":"35","key":"897_CR171","doi-asserted-by":"publisher","first-page":"15467","DOI":"10.1073\/pnas.1000462107","volume":"107","author":"CH Ha","year":"2010","unstructured":"Ha CH, Kim JY, Zhao J, Wang W, Jhun BS, Wong C, et al. PKA phosphorylates histone deacetylase 5 and prevents its nuclear export, leading to the inhibition of gene transcription and cardiomyocyte hypertrophy. Proc Natl Acad Sci. 2010;107(35):15467\u201372.","journal-title":"Proc Natl Acad Sci"},{"issue":"1\u20132","key":"897_CR172","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.mce.2007.09.007","volume":"286","author":"C Viollet","year":"2008","unstructured":"Viollet C, Lepousez G, Loudes C, Videau C, Simon A, Epelbaum J. Somatostatinergic systems in brain: Networks and functions. Mol Cell Endocrinol. 2008;286(1\u20132):75\u201387.","journal-title":"Mol Cell Endocrinol"},{"issue":"9","key":"897_CR173","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/0026-0495(90)90226-3","volume":"39","author":"MF Beal","year":"1990","unstructured":"Beal MF. Somatostatin in neurodegenerative illnesses. Metabolism. 1990;39(9):116\u20139.","journal-title":"Metabolism"},{"issue":"3","key":"897_CR174","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/s12276-021-00580-4","volume":"53","author":"YH Song","year":"2021","unstructured":"Song YH, Yoon J, Lee SH. The Role of Neuropeptide Somatostatin in the Brain and Its Application in Treating Neurological Disorders. Exp Mol Med. 2021;53(3):328\u201338.","journal-title":"Exp Mol Med"},{"key":"897_CR175","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3389\/fnins.2020.00096","volume":"14","author":"D Saiz-Sanchez","year":"2020","unstructured":"Saiz-Sanchez D, Ubeda-Ba\u00f1on I, Flores-Cuadrado A, Gonzalez-Rodriguez M, Villar-Conde S, Astillero-Lopez V. Somatostatin, olfaction, and neurodegeneration. Front Neurosci. 2020;14:96.","journal-title":"Front Neurosci"},{"key":"897_CR176","doi-asserted-by":"publisher","first-page":"122173","DOI":"10.1016\/j.lfs.2023.122173","volume":"334","author":"MJ Klomp","year":"2023","unstructured":"Klomp MJ, Van DBL, Van KPM, De RCM, Stuurman DC, L\u00f6wik CW, et al. Applying HDACIs to increase SSTR2 expression and radiolabeled DOTA-TATE uptake: From cells to mice. Life Sci. 2023;334:122173.","journal-title":"Life Sci"},{"issue":"9","key":"897_CR177","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1158\/1535-7163.MCT-22-0798","volume":"22","author":"R Sharma","year":"2023","unstructured":"Sharma R, Earla B, Baidoo KE, Zeiger MA, Madigan JP, Escorcia FE, et al. Upregulation of somatostatin receptor Type 2 improves 177Lu-DOTATATE therapy in receptor-deficient pancreatic neuroendocrine tumor model. Mol Cancer Ther. 2023;22(9):1052\u201362.","journal-title":"Mol Cancer Ther"},{"key":"897_CR178","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1159\/000334106","volume":"59","author":"A Lacquaniti","year":"2011","unstructured":"Lacquaniti A, Donato V, Chirico V, Buemi A, Buemi M. Obestatin: An Interesting but Controversial Gut Hormone. Ann Nut Metab. 2011;59:193\u20139.","journal-title":"Ann Nut Metab"},{"key":"897_CR179","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.peptides.2017.02.005","volume":"90","author":"T Koyuncuoglu","year":"2017","unstructured":"Koyuncuoglu T, Vizdiklar C, Uren D, Yilmaz H, Yildirim C, Atal SS, et al. Obestatin improves oxidative brain damage and memory dysfunction in rats induced with an epileptic seizure. Peptides. 2017;90:37\u201347.","journal-title":"Peptides"},{"key":"897_CR180","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.peptides.2007.04.003","volume":"28","author":"BD Obay","year":"2007","unstructured":"Obay BD, Tasdemir E, T\u00fcmer C, Bilgin HM, Sermet A. Antiepileptic effects of ghrelin on pentylenetetrazole-induced seizures in rats. Peptides. 2007;28:1214\u20139.","journal-title":"Peptides"},{"key":"897_CR181","first-page":"9163040","volume":"2018","author":"M Weng","year":"2018","unstructured":"Weng M, Xie X, Liu C, Lim KL, Zhang CW, Li L. The sources of reactive oxygen species and its possible role in the pathogenesis of Parkinson\u2019s disease. Parkinsons Dis. 2018;2018:9163040.","journal-title":"Parkinsons Dis"},{"key":"897_CR182","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.biopha.2017.11.036","volume":"97","author":"Y Liu","year":"2018","unstructured":"Liu Y, Xing YX, Gao XY, Kuang HY, Zhang J, Liu R. Obestatin prevents H2O2-induced damage through activation of TrkB in RGC-5 cells. Biomed Pharmacother. 2018;97:1061\u20135.","journal-title":"Biomed Pharmacother"},{"key":"897_CR183","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1038\/s41598-017-02337-4","volume":"7","author":"SI Zas","year":"2017","unstructured":"Zas SI, Cid DT, Gonzalez SJ, Gurriaran RU, Seoane MC, Porteiro B, et al. Obestatin controls skeletal muscle fiber-type determination. Sci Rep. 2017;7:2137.","journal-title":"Sci Rep"},{"issue":"4","key":"897_CR184","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3390\/biom12040517","volume":"12","author":"D Villarreal","year":"2022","unstructured":"Villarreal D, Pradhan G, Zhou Y, Xue B, Sun Y. Diverse and complementary effects of ghrelin and obestatin. Biomolecules. 2022;12(4):517.","journal-title":"Biomolecules"},{"issue":"6","key":"897_CR185","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1002\/jcsm.12338","volume":"9","author":"SJ Gonzalez","year":"2018","unstructured":"Gonzalez SJ, Sanchez TA, Cid DT, Pabst FR, Mosteiro CS, Gallego R, et al. Improvement of duchenne muscular dystrophy phenotype following obestatin treatment. J Cachexia Sarcopenia Muscle. 2018;9(6):1063\u201378.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"12","key":"897_CR186","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1097\/WNR.0000000000001693","volume":"32","author":"LJ Zhu","year":"2021","unstructured":"Zhu LJ, Sun YQ, Wang S, Shi HJ, Li N. Involvement of 5-HT1a receptor-mediated histone acetylation in the regulation of depression. NeuroReport. 2021;32(12):1049\u201357.","journal-title":"NeuroReport"},{"issue":"9","key":"897_CR187","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1038\/nn.4616","volume":"20","author":"D Ibi","year":"2017","unstructured":"Ibi D, Fuente RM, Kezunovic N, Muguruza C, Saunders JM, Gaitonde SA, et al. Antipsychotic-induced HDAC2 transcription via NF-\u03baB leads to synaptic and cognitive side effects. Nat Neurosci. 2017;20(9):1247\u201359.","journal-title":"Nat Neurosci"},{"issue":"1","key":"897_CR188","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1038\/s41467-019-11031-0","volume":"10","author":"TM Gilbert","year":"2019","unstructured":"Gilbert TM, Z\u00fcrcher NR, Catanese MC, Tseng CE, Di BMA, Lyall AE, Hightower BG, Parmar AJ, Bhanot A, Wu CJ, Hibert ML. Neuroepigenetic signatures of age and sex in the living human brain. Nat Commun. 2019;10(1):2945.","journal-title":"Nat Commun"},{"issue":"17","key":"897_CR189","doi-asserted-by":"publisher","first-page":"1900001","DOI":"10.1002\/mnfr.201900001","volume":"63","author":"A Xing","year":"2019","unstructured":"Xing A, Li X, Jiang C, Chen Y, Wu S, Zhang J, et al. As a histone deacetylase inhibitor, \u03b3-aminobutyric acid upregulates Glur2 expression: an in vitro and in vivo Study. Mol Nutr Food Res. 2019;63(17):1900001.","journal-title":"Mol Nutr Food Res"},{"issue":"4","key":"897_CR190","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.neuint.2010.01.007","volume":"56","author":"S Aizawa","year":"2010","unstructured":"Aizawa S, Yamamuro Y. Involvement of histone acetylation in the regulation of choline acetyltransferase gene in NG108-15 neuronal cells. Neurochem Int. 2010;56(4):627\u201333.","journal-title":"Neurochem Int"},{"key":"897_CR191","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.neuroscience.2011.12.024","volume":"205","author":"S Aizawa","year":"2012","unstructured":"Aizawa S, Teramoto K, Yamamuro Y. Histone deacetylase 9 as a negative regulator for choline acetyltransferase gene in NG108-15 neuronal cells. Neuroscience. 2012;205:63\u201372.","journal-title":"Neuroscience"},{"issue":"11","key":"897_CR192","doi-asserted-by":"publisher","first-page":"691","DOI":"10.21037\/atm-20-4330","volume":"8","author":"K Tao","year":"2020","unstructured":"Tao K, Cai Q, Zhang X, Zhu L, Liu Z, Li F, et al. Astrocytic histone deacetylase 2 facilitates delayed depression and memory impairment after subarachnoid haemorrhage by negatively regulating glutamate transporter-1. Ann Transl Med. 2020;8(11):691.","journal-title":"Ann Transl Med"},{"issue":"21","key":"897_CR193","doi-asserted-by":"publisher","first-page":"4631","DOI":"10.3390\/nu15214631","volume":"15","author":"Y Zheng","year":"2023","unstructured":"Zheng Y, Bonfili L, Wei T, Eleuteri AM. Understanding the gut\u2013brain axis and its therapeutic implications for neurodegenerative disorders. Nutrients. 2023;15(21):4631.","journal-title":"Nutrients"},{"issue":"1","key":"897_CR194","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1515\/tnsci-2016-0007","volume":"7","author":"SD Svob","year":"2016","unstructured":"Svob SD, Pivac N, M\u00fcck SD. The serotonergic system and cognitive function. Transl Neurosci. 2016;7(1):35\u201349.","journal-title":"Transl Neurosci"},{"issue":"2","key":"897_CR195","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/fsn3.3826","volume":"12","author":"N Akram","year":"2023","unstructured":"Akram N, Faisal Z, Irfan R, Shah YA, Batool SA, Zahid T, et al. Exploring the serotonin-probiotics-gut health axis: a review of current evidence and potential mechanisms. Food Sci Nutr. 2023;12(2):694\u2013706.","journal-title":"Food Sci Nutr"},{"key":"897_CR196","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.neulet.2015.03.028","volume":"593","author":"N Asaoka","year":"2015","unstructured":"Asaoka N, Nagayasu K, Nishitani N, Yamashiro M, Shirakawa H, Nakagawa T, et al. Inhibition of histone deacetylases enhances the function of serotoninergic neurons in organotypic raphe slice cultures. Neurosci Lett. 2015;593:72\u20137.","journal-title":"Neurosci Lett"},{"key":"897_CR197","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/7854_2021_222","volume":"52","author":"AP Princivalle","year":"2022","unstructured":"Princivalle AP. GABAB Receptors in Neurodegeneration. Curr Top Behav Neurosci. 2022;52:267\u201390.","journal-title":"Curr Top Behav Neurosci"},{"issue":"1","key":"897_CR198","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s40001-024-01779-7","volume":"29","author":"B Alharbi","year":"2024","unstructured":"Alharbi B, Kuraishy HM, Gareeb AI, Elekhnawy E, Alharbi H, Alexiou A, et al. Role of GABA pathway in motor and non-motor symptoms in Parkinson\u2019s disease: A bidirectional circuit. Eur J Med Res. 2024;29(1):205.","journal-title":"Eur J Med Res"},{"issue":"1","key":"897_CR199","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41538-024-00253-2","volume":"8","author":"JD Braga","year":"2024","unstructured":"Braga JD, Thongngam M, Kumrungsee T. Gamma-aminobutyric acid as a potential postbiotic mediator in the gut\u2013brain axis. Npj Sci Food. 2024;8(1):16.","journal-title":"Npj Sci Food"},{"key":"897_CR200","doi-asserted-by":"crossref","unstructured":"Ullah H, Arbab S, Tian Y, Liu CQ, Chen Y, Qijie L, et al. The gut microbiota\u2013brain axis in neurological disorder. Front Neurosci. 2023;17(17):1225875.","DOI":"10.3389\/fnins.2023.1225875"},{"key":"897_CR201","first-page":"143269","volume":"1","author":"K Xu","year":"2011","unstructured":"Xu K, Dai XL, Huang HC, Jiang ZF, Targeting HDAC. A promising therapy for Alzheimer\u2032s disease. Oxid Med Cell Longev. 2011;1:143269.","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"897_CR202","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1124\/jpet.121.000735","volume":"379","author":"SH Li","year":"2021","unstructured":"Li SH, Colson TL, Abd-Elrahman KS, Ferguson SS. Metabotropic glutamate receptor 2\/3 activation improves motor performance and reduces pathology in heterozygous Zq175 Huntington\u2019s disease mice. J Pharmacol Exp Ther. 2021;379(1):74\u201384.","journal-title":"J Pharmacol Exp Ther"},{"key":"897_CR203","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.bbi.2021.10.007","volume":"99","author":"G \u00c7al\u0131\u015fkan","year":"2022","unstructured":"\u00c7al\u0131\u015fkan G, French T, Lacalle SE, Del Angel M, Steffen J, Heimesaat MM, et al. Antibiotic-induced gut dysbiosis leads to activation of microglia and impairment of cholinergic gamma oscillations in the hippocampus. Brain Behav Immun. 2022;99:203\u201317.","journal-title":"Brain Behav Immun"},{"issue":"4","key":"897_CR204","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.3233\/JAD-161118","volume":"57","author":"R Kandimalla","year":"2017","unstructured":"Kandimalla R, Reddy PH. Therapeutics of in Alzheimer\u2019s disease. J Alzheimers Dis. 2017;57(4):1049\u201369.","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"897_CR205","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3109\/10409237709105460","volume":"4","author":"HG Mautner","year":"1977","unstructured":"Mautner HG. Choline Acetyltransferase. CRC Crit Rev Biochem. 1977;4(4):341\u201370.","journal-title":"CRC Crit Rev Biochem"},{"key":"897_CR206","doi-asserted-by":"publisher","first-page":"101994","DOI":"10.1016\/j.arr.2023.101994","volume":"89","author":"M Nimgampalle","year":"2023","unstructured":"Nimgampalle M, Chakravarthy H, Sharma S, Shree S, Bhat AR, Pradeepkiran JA, et al. Neurotransmitter systems in the etiologic of major neurological disorders: emerging insights and therapeutic implications. Ageing Res Rev. 2023;89:101994.","journal-title":"Ageing Res Rev"},{"issue":"7981","key":"897_CR207","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41586-023-06502-w","volume":"622","author":"CR De","year":"2023","unstructured":"De CR, Ledonne A, Litvin DG, Lind BL, Carriero G, Latagliata EC, et al. Specialized astrocytes mediate glutamatergic gliotransmission in the CNS. Nature. 2023;622(7981):120\u20139.","journal-title":"Nature"},{"issue":"9","key":"897_CR208","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1038\/s41593-023-01406-4","volume":"26","author":"K Noh","year":"2023","unstructured":"Noh K, Cho WH, Lee BH, Kim DW, Kim YS, Park K, et al. Cortical astrocytes modulate dominance behavior in male mice by regulating synaptic excitatory and inhibitory balance. Nat Neurosci. 2023;26(9):1541\u201354.","journal-title":"Nat Neurosci"},{"issue":"10","key":"897_CR209","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.tins.2021.07.004","volume":"44","author":"C Durkee","year":"2021","unstructured":"Durkee C, Kofuji P, Navarrete M, Araque A. Astrocyte and neuron cooperation in long-term depression. Trends Neurosci. 2021;44(10):837\u201348.","journal-title":"Trends Neurosci"},{"issue":"20","key":"897_CR210","doi-asserted-by":"publisher","first-page":"7452","DOI":"10.3390\/ijms21207452","volume":"21","author":"VN Bukke","year":"2020","unstructured":"Bukke VN, Archana M, Villani R, Romano AD, Wawrzyniak A, Balawender K, et al. The Dual role of glutamatergic neurotransmission in Alzheimer\u2019s disease: From pathophysiology to pharmacotherapy. Int J Mol Sci. 2020;21(20):7452.","journal-title":"Int J Mol Sci"},{"issue":"24","key":"897_CR211","doi-asserted-by":"publisher","first-page":"9607","DOI":"10.3390\/ijms21249607","volume":"21","author":"AC Todd","year":"2020","unstructured":"Todd AC, Hardingham GE. The regulation of astrocytic glutamate transporters in health and neurodegenerative diseases. Int J Mol Sci. 2020;21(24):9607.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"897_CR212","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.3390\/nu13062099","volume":"13","author":"Y Chen","year":"2021","unstructured":"Chen Y, Xu J, Chen Y. Regulation of neurotransmitters by the gut microbiota and effects on cognition in neurological disorders. Nutrients. 2021;13(6):2099.","journal-title":"Nutrients"},{"issue":"1","key":"897_CR213","doi-asserted-by":"publisher","first-page":"6958","DOI":"10.1038\/s41467-022-34667-x","volume":"13","author":"ZD Wallen","year":"2022","unstructured":"Wallen ZD, Demirkan A, Twa G, Cohen G, Dean MN, Standaert DG, et al. Metagenomics of Parkinson\u2019s disease implicates the gut microbiome in multiple disease mechanisms. Nat Commun. 2022;13(1):6958.","journal-title":"Nat Commun"},{"issue":"5","key":"897_CR214","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.cmet.2022.04.001","volume":"34","author":"J Mayneris","year":"2022","unstructured":"Mayneris J, Castells NA, Arnoriaga RM, Martin M, Correa DLVL, Zapata C, et al. Microbiota alterations in proline metabolism impact depression. Cell Metabol. 2022;34(5):681\u2013701.","journal-title":"Cell Metabol"},{"issue":"2","key":"897_CR215","doi-asserted-by":"publisher","first-page":"Eaau8317","DOI":"10.1126\/sciadv.aau8317","volume":"5","author":"P Zheng","year":"2019","unstructured":"Zheng P, Zeng B, Liu M, Chen J, Pan J, Han Y, et al. The gut microbiome from patients with schizophrenia modulates the glutamate-glutamine-GABA cycle and schizophrenia-relevant behaviours in mice. Sci Adv. 2019;5(2):Eaau8317.","journal-title":"Sci Adv"},{"issue":"8","key":"897_CR216","doi-asserted-by":"publisher","first-page":"2676","DOI":"10.3390\/ijms21082676","volume":"21","author":"CH Chang","year":"2020","unstructured":"Chang CH, Lin CH, Lane HY. D-Glutamate and gut microbiota in Alzheimer\u2019s disease. Int J Mol Sci. 2020;21(8):2676.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"897_CR217","first-page":"869647","volume":"2011","author":"PV Licciardi","year":"2011","unstructured":"Licciardi PV, Ververis K, Karagiannis TC. histone deacetylase inhibition and dietary short-chain fatty acids. ISRN Biochem. 2011;2011(1):869647.","journal-title":"ISRN Biochem"},{"issue":"9","key":"897_CR218","doi-asserted-by":"publisher","first-page":"4942","DOI":"10.3390\/ijms25094942","volume":"25","author":"V Abrignani","year":"2024","unstructured":"Abrignani V, Salvo A, Pacinella G, Tuttolomondo A. The Mediterranean diet, its microbiome connections, and cardiovascular health: A narrative review. Int Int J Mol Sci. 2024;25(9):4942.","journal-title":"Int Int J Mol Sci"},{"issue":"11","key":"897_CR219","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41579-024-01068-4","volume":"22","author":"FC Ross","year":"2024","unstructured":"Ross FC, Patangia D, Grimaud G, Lavelle A, Dempsey EM, Ross RP, et al. The interplay between diet and the gut microbiome: Implications for health and disease. Nat Rev Microbiol. 2024;22(11):671\u201386.","journal-title":"Nat Rev Microbiol"},{"issue":"6","key":"897_CR220","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.cell.2020.04.027","volume":"181","author":"QY Ang","year":"2020","unstructured":"Ang QY, Alexander M, Newman JC, Tian Y, Cai J, Upadhyay V, et al. Ketogenic diets alter the gut microbiome resulting in decreased intestinal Th17 cells. Cell. 2020;181(6):1263\u201375.","journal-title":"Cell"},{"issue":"1","key":"897_CR221","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.gene.2015.02.045","volume":"562","author":"F Vahid","year":"2015","unstructured":"Vahid F, Zand H, Nosrat ME, Najafi R, Hekmatdoost A. The role dietary of bioactive compounds on the regulation of histone acetylases and deacetylases: A review. Gene. 2015;562(1):8\u201315.","journal-title":"Gene"},{"issue":"4","key":"897_CR222","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.advnut.2023.04.005","volume":"14","author":"G Zhu","year":"2023","unstructured":"Zhu G, Zhao J, Zhang H, Wang G, Chen W. Gut microbiota and its metabolites: Bridge of dietary nutrients and Alzheimer\u2019s disease. Adv Nutr. 2023;14(4):819\u201339.","journal-title":"Adv Nutr"},{"issue":"2","key":"897_CR223","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s13668-019-0271-4","volume":"8","author":"AM Mcgrattan","year":"2019","unstructured":"Mcgrattan AM, Mcguinness B, Mckinley MC, Kee F, Passmore P, Woodside JV, et al. Diet and inflammation in cognitive ageing and Alzheimer\u2019s disease. Curr Nutr Rep. 2019;8(2):53\u201365.","journal-title":"Curr Nutr Rep"},{"issue":"3","key":"897_CR224","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3390\/nu8030144","volume":"8","author":"M Canevelli","year":"2016","unstructured":"Canevelli M, Lucchini F, Quarata F, Bruno G, Cesari M. Nutrition and dementia: Evidence for preventive approaches. Nutrients. 2016;8(3):144.","journal-title":"Nutrients"},{"issue":"4","key":"897_CR225","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3390\/antiox6040081","volume":"6","author":"DW Wilson","year":"2017","unstructured":"Wilson DW, Nash P, Buttar HS, Griffiths K, Singh R, De Meester F, et al. The role of food antioxidants, benefits of functional foods, and influence of feeding habits on the health of the older person: An overview. Antioxidants. 2017;6(4):81.","journal-title":"Antioxidants"},{"key":"897_CR226","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3389\/fnagi.2019.00369","volume":"11","author":"GK Bhatti","year":"2020","unstructured":"Bhatti GK, Reddy AP, Reddy PH, Bhatti JS. Lifestyle modifications and nutritional interventions in aging-associated cognitive decline and Alzheimer\u2019s disease. Front Aging Neurosci. 2020;11:369.","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"897_CR227","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/MOL.0000000000000862","volume":"34","author":"FK Welty","year":"2023","unstructured":"Welty FK. Omega-3 fatty acids and cognitive function. Curr Opin Lipidol. 2023;34(1):12\u201321.","journal-title":"Curr Opin Lipidol"},{"issue":"1","key":"897_CR228","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s10571-025-01543-3","volume":"45","author":"J Tian","year":"2025","unstructured":"Tian J, Zhang Y, Zhao X. The effects and mechanisms of N-3 And N-6 polyunsaturated fatty acids in the central nervous system. Cell Mol Neurobiol. 2025;45(1):25.","journal-title":"Cell Mol Neurobiol"},{"key":"897_CR229","doi-asserted-by":"crossref","unstructured":"Ali S, Hamayun M, Siraj M, Khan SA, Kim HY, Lee B. Recent advances in prebiotics: classification, mechanisms, and health applications. Future Foods. 2025;12:100680.","DOI":"10.1016\/j.fufo.2025.100680"},{"issue":"3","key":"897_CR230","doi-asserted-by":"publisher","first-page":"635","DOI":"10.3390\/nu11030635","volume":"11","author":"T Cerd\u00f3","year":"2019","unstructured":"Cerd\u00f3 T, Garc\u00eda JA, Berm\u00fadez GM, Campoy C. The role of probiotics and prebiotics in the prevention and treatment of obesity. Nutrients. 2019;11(3):635.","journal-title":"Nutrients"},{"issue":"8","key":"897_CR231","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.tim.2021.01.003","volume":"29","author":"M Cunningham","year":"2021","unstructured":"Cunningham M, Azcarate MA, Barnard A, Benoit V, Grimaldi R, Guyonnet D, et al. Shaping the future of probiotics and prebiotics. Trends Microbiol. 2021;29(8):667\u201385.","journal-title":"Trends Microbiol"},{"issue":"3","key":"897_CR232","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s12263-010-0206-6","volume":"6","author":"K Pokusaeva","year":"2011","unstructured":"Pokusaeva K, Fitzgerald GF, Van Sinderen D. Carbohydrate metabolism in Bifidobacteria. Genes Nutr. 2011;6(3):285\u2013306.","journal-title":"Genes Nutr"},{"key":"897_CR233","doi-asserted-by":"publisher","first-page":"6025","DOI":"10.2147\/JIR.S300989","volume":"18","author":"MT Siddiqui","year":"2021","unstructured":"Siddiqui MT, Cresci GA. The immunomodulatory functions of butyrate. J Inflamm Res. 2021;18:6025\u201341.","journal-title":"J Inflamm Res"},{"key":"897_CR234","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fendo.2020.00025","volume":"11","author":"YP Silva","year":"2020","unstructured":"Silva YP, Bernardi A, Frozza RL. The role of short-chain fatty acids from gut microbiota in gut-brain communication. Front Endocrinol (Lausanne). 2020;11:25.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"897_CR235","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.neuropharm.2019.02.014","volume":"150","author":"AC Kao","year":"2019","unstructured":"Kao AC, Chan KW, Anthony DC, Lennox BR, Burnet PW. Prebiotic reduction of brain histone deacetylase (HDAC) activity and olanzapine-mediated weight gain in rats is acetate independent. Neuropharmacology. 2019;150:184\u201391.","journal-title":"Neuropharmacology"},{"key":"897_CR236","doi-asserted-by":"crossref","first-page":"2515690X2095722","DOI":"10.1177\/2515690X20957225","volume":"22","author":"CT Peterson","year":"2020","unstructured":"Peterson CT. Dysfunction of the microbiota-gut-brain axis in neurodegenerative disease: The promise of therapeutic modulation with prebiotics, Medicinal Herbs, Probiotics, and Synbiotics. J Evid Based Integr Med. 2020;22:25:2515690X20957225.","journal-title":"J Evid Based Integr Med"},{"issue":"1","key":"897_CR237","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1038\/s42003-022-04295-8","volume":"5","author":"A Labarre","year":"2022","unstructured":"Labarre A, Guitard E, Tossing G, Forest A, Bareke E, Labrecque M, et al. Fatty acids derived from the probiotic Lacticaseibacillus rhamnosus HA-114 suppress age-dependent neurodegeneration. Commun Biol. 2022;5(1):1340.","journal-title":"Commun Biol"},{"key":"897_CR238","doi-asserted-by":"publisher","first-page":"902205","DOI":"10.3389\/fnins.2022.902205","volume":"16","author":"A Chongtham","year":"2022","unstructured":"Chongtham A, Yoo JH, Chin TM, Akingbesote ND, Huda A, Marsh JL, et al. Gut bacteria regulate the pathogenesis of Huntington\u2019s disease in drosophila model. Front Neurosci. 2022;16:902205.","journal-title":"Front Neurosci"},{"issue":"1","key":"897_CR239","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13195-020-00649-8","volume":"12","author":"CN Suire","year":"2020","unstructured":"Suire CN, Abdul-Hay SO, Sahara T, Kang D, Brizuela MK, Saftig P, et al. Cathepsin D regulates cerebral A\u03b242\/40 ratios via differential degradation of A\u03b242 and A\u03b240. Alzheimer\u2019s Res Ther. 2020;12(1):80.","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"897_CR240","first-page":"114816","volume":"163","author":"S Aghamohammad","year":"2023","unstructured":"Aghamohammad S, Hafezi A, Rohani M. Probiotics as functional foods: How probiotics can alleviate the symptoms of neurological disabilities. BiomedPharmacother. 2023;163:114816.","journal-title":"BiomedPharmacother"},{"issue":"4","key":"897_CR241","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.3390\/microorganisms11041083","volume":"11","author":"S Ojha","year":"2023","unstructured":"Ojha S, Patil N, Jain M, Kole C, Kaushik P. Probiotics for neurodegenerative diseases: A systemic review. Microorganisms. 2023;11(4):1083.","journal-title":"Microorganisms"},{"issue":"3","key":"897_CR242","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3390\/biom11030433","volume":"11","author":"M Lorente-Pic\u00f3n","year":"2021","unstructured":"Lorente-Pic\u00f3n M, Laguna A. New avenues for Parkinson\u2019s disease therapeutics: disease-modifying strategies based on the gut microbiota. Biomolecules. 2021;11(3):433.","journal-title":"Biomolecules"},{"issue":"18","key":"897_CR243","doi-asserted-by":"publisher","first-page":"2200164","DOI":"10.1002\/mnfr.202200164","volume":"66","author":"L Song","year":"2022","unstructured":"Song L, Sun Q, Zheng H, Zhang Y, Wang Y, Liu S, et al. Roseburia hominis alleviates neuroinflammation via short-chain fatty acids through histone deacetylase inhibition. Mol Nutr Food Res. 2022;66(18):2200164.","journal-title":"Mol Nutr Food Res"},{"issue":"10","key":"897_CR244","doi-asserted-by":"publisher","first-page":"7987","DOI":"10.1007\/s12035-018-0973-4","volume":"55","author":"L Bonfili","year":"2018","unstructured":"Bonfili L, Cecarini V, Cuccioloni M, Angeletti M, Berardi S, Scarpona S, et al. SLAB51 probiotic formulation activates SIRT1 pathway promoting antioxidant and neuroprotective effects in an AD mouse model. Mol Neurobiol. 2018;55(10):7987\u20138000.","journal-title":"Mol Neurobiol"},{"key":"897_CR245","first-page":"20","volume":"1","author":"IA Onifade","year":"2024","unstructured":"Onifade IA, Sunbare-Funto OJ, Mbah CE, Ajibade OA, Oyawoye OM, Aborode AT, et al. Faecal microbial transplant. Adv Biomark Sci Technol. 2024;1:6:20\u201334.","journal-title":"Adv Biomark Sci Technol"},{"key":"897_CR246","doi-asserted-by":"crossref","unstructured":"Allegretti JR, Korzenik JR, Hamilton MJ. Fecal microbiota transplantation via colonoscopy for recurrent C. difficile infection. J Vis Exp. 2014;94(94):52154.","DOI":"10.3791\/52154"},{"key":"897_CR247","doi-asserted-by":"publisher","first-page":"481","DOI":"10.2147\/BTT.S486372","volume":"31","author":"H Baydoun","year":"2025","unstructured":"Baydoun H, Hussain N, Wu KO, Kelly CR, Fischer M. What\u2019s new and what\u2019s next in fecal microbiota transplantation. Biol Targets Ther. 2025;31:481\u201396.","journal-title":"Biol Targets Ther"},{"issue":"1","key":"897_CR248","doi-asserted-by":"publisher","first-page":"E70012","DOI":"10.1111\/gbb.70012","volume":"24","author":"C Chevalier","year":"2025","unstructured":"Chevalier C, Tournier BB, Marizzoni M, Park R, Paquis A, Ceyz\u00e9riat K, et al. Fecal microbiota transplantation (FMT) from a human at low risk for Alzheimer\u2019s disease improves short-term recognition memory and increases neuroinflammation in a 3xTg ad mouse model. Genes Brain Behav. 2025;24(1):E70012.","journal-title":"Genes Brain Behav"},{"issue":"1","key":"897_CR249","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12993-024-00265-8","volume":"21","author":"X Li","year":"2025","unstructured":"Li X, Ding Q, Wan X, Wu Q, Ye S, Lou Y. Fecal microbiota transplantation attenuates Alzheimer\u2019s disease symptoms in APP\/PS1 transgenic mice via inhibition of the TLR4-Myd88-Nf\u03bab signalling pathway-mediated inflammation. Behav Brain Funct. 2025;21(1):2.","journal-title":"Behav Brain Funct"},{"issue":"6","key":"897_CR250","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.14336\/AD.2023.0309","volume":"14","author":"Z Xie","year":"2023","unstructured":"Xie Z, Zhang M, Luo Y, Jin D, Guo X, Yang W, Zheng J, et al. Healthy human fecal microbiota transplantation into mice attenuates MPTP-induced neurotoxicity via AMPK\/SOD2 pathway. Aging disease. 2023;14(6):2193.","journal-title":"Aging disease"},{"issue":"4","key":"897_CR251","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3390\/medsci6040086","volume":"6","author":"A Paule","year":"2018","unstructured":"Paule A, Frezza D, Edeas M. Microbiota and phage therapy: Future challenges in medicine. Med Sci. 2018;6(4):86.","journal-title":"Med Sci"},{"issue":"8","key":"897_CR252","doi-asserted-by":"publisher","first-page":"985","DOI":"10.3390\/antiox13080985","volume":"13","author":"AH Mostafavi","year":"2024","unstructured":"Mostafavi AH, Zhou JR. Gut Microbiota Dysbiosis, Oxidative Stress, Inflammation, And Epigenetic Alterations in Metabolic Diseases. Antioxidants. 2024;13(8):985.","journal-title":"Antioxidants"},{"issue":"8","key":"897_CR253","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.3390\/v15081736","volume":"15","author":"S Lv","year":"2023","unstructured":"Lv S, Wang Y, Jiang K, Guo X, Zhang J, Zhou F, et al. Genetic engineering and biosynthesis technology: Keys to unlocking the chains of phage therapy. Viruses. 2023;15(8):1736.","journal-title":"Viruses"},{"issue":"2","key":"897_CR254","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.gene.2016.02.005","volume":"583","author":"J Messing","year":"2016","unstructured":"Messing J. Phage M13 for the treatment of Alzheimer\u2019s and Parkinson\u2019s disease. Gene. 2016;583(2):85\u20139.","journal-title":"Gene"},{"issue":"5","key":"897_CR255","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.7150\/thno.68636","volume":"12","author":"X Zhang","year":"2022","unstructured":"Zhang X, Zhang X, Gao H, Qing G. Phage display derived peptides for Alzheimer\u2019s disease therapy and diagnosis. Theranostics. 2022;12(5):2041.","journal-title":"Theranostics"},{"key":"897_CR256","doi-asserted-by":"publisher","first-page":"100612","DOI":"10.1016\/j.mtbio.2023.100612","volume":"20","author":"C Chang","year":"2023","unstructured":"Chang C, Guo W, Yu X, Guo C, Zhou N, Guo X, et al. Engineered M13 phage as a novel therapeutic bionanomaterial for clinical applications: From tissue regeneration to cancer therapy. Mater Today Bio. 2023;20:100612.","journal-title":"Mater Today Bio"},{"issue":"13","key":"897_CR257","doi-asserted-by":"publisher","first-page":"6183","DOI":"10.3390\/ijms26136183","volume":"26","author":"V Salari","year":"2025","unstructured":"Salari V, Parrella E, Mengoni F, Cintra L, Bertini G, Fabene PF. Phage-microbiota crosstalk: implications for central nervous system disorders. Int J Mol Sci. 2025;26(13):6183.","journal-title":"Int J Mol Sci"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-026-00897-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-026-00897-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-026-00897-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:03:40Z","timestamp":1788966220000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-026-00897-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":257,"alternative-id":["897"],"URL":"https:\/\/doi.org\/10.1007\/s43440-026-00897-9","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]},"assertion":[{"value":"26 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors edited and improved this manuscript using QuillBot and Grammarly. All AI content was reviewed, verified, and finalised by the authors. Figures were created using Microsoft PowerPoint, ChemDraw, and QuillBot and edited using Paint 3D and FastStone.","order":2,"name":"Ethics","label":"AI and software disclosure statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}